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1.1 Current available minimally invasive or extracorporeal treatments.
(a) A schematic of the extracorporeal shock wave lithotripter designed
by [6]. (b) An example of cryoablation of an exophytic renal tumor,
where two cyroprobes are labeled along with an US probe for real-time
monitoring. Adapted from [7]. (c) As seen in this frontal angiogram,
an RF probe with deployed hooks, as illustrated by long arrows, is
inserted into the nodule of a hepatocellular carcinoma. Blood flow is
occluded with a balloon catheter (short arrow) in the hepatic artery
[8]. (d) shows the Model JC Haifu system (Chongqing Haifu Tech-
nology Co., Ltd., Chongqing, China) used for HIFU treatment [9].
Images were collected from the above cited references. . . . . . . . . 4
2.1 (a) Top view of the experimental setup for measurements performed in
a static environment. The therapeutic transducer and the associated
electronics necessary to create millisecond pulses are shown. Both
methods of detection also are illustrated and labeled as Detector 1 and
Detector 2, though they were not used concurrently. (b) Schematic
(side view) of the experimental setup used in studies measuring ADV
threshold in the presence of contrast agents in a flow environment.
Solutions contained either droplets, droplets and 103, 104, or 105 mi-
crospheres/mL of Definity R©, or 105 microspheres/mL of Definity R©.
Experiments were performed in 37◦C deionized water. . . . . . . . . 27
2.2 Example of REA against Pr for 500 µs pulses. The sharp change in
slope at approximately 5.5 MPa reflects a rise in REA due to bubbles
created by ADV. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32
2.3 Threshold in Pr as detected in B-mode images. Error bars reflect the
standard error of the mean. (∗) Refers to 1000 pulses (20 µs each in
duration) at a PRF of 500 Hz. All other data points are the thresholds
for single pulses with pulse durations indicated along the abscissa. . 33
viii
2.4 (a) Sequential frames of a B-mode movie show effects of a 20 ms
pulse at 1.86 MPa Pr . Frame 2 immediately follows the tone burst in
Frame 1, during which acoustic interference was seen and thus is not
shown here. The tube was oriented vertically, and the imager as well
as the annular transducer was positioned to the left of these images.
Echogenic scatterers, nonbubbles, sink toward the bottom of the tube
as indicated by the circles in Frames 10 and 20. (b) Sequential frames
of a B-mode cineloop show effects of a 20 ms pulse at 3.74 MPa Pr
. Frame 3 immediately follows the tone burst, during which acoustic
interference was seen. Acoustic interference may span from one to
two frames; in this case, interference spanned from Frame 1 to 2.
Due to radiation force, the echogenic scatterers were pushed against
the tube wall, then dispersed above and below the beam. However,
the scatterers in these images rise toward the top against gravity,
indicating the creation of bubbles, and therefore, the occurrence of
ADV. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41
2.5 ADV threshold experiment for 10 ms tone bursts. (a) Example of the
spectral content of a subharmonic frequency band in terms of Vrms
plotted against Pr. A histogram of the Vrms values is seen in (b),
in which the lowest Vrms values can be separated (↓) as the baseline
values. Vrms values greater than the baseline value (-) are determined
as above threshold. . . . . . . . . . . . . . . . . . . . . . . . . . . . 42
2.6 Threshold in Pr as detected by the passive 5 MHz passive transducer.
Error bars reflect the standard error of the mean. (∗) Refers to 1000
pulses (20 µs each in duration) at a PRF of 500 Hz. (a) Shows thresh-
old measurements based on RMS values of the subharmonic range
from 0.7-0.74 MHz. (b) Shows threshold measurements based on the
presence of broadband noise. . . . . . . . . . . . . . . . . . . . . . . 42
2.7 RF signals are displayed for single (a) 20 ms tone bursts and for
(b) 1000 pulses (20 µs each in duration) at a PRF of 500 Hz for
various pressure amplitudes. The associated time-frequency plots of
the acoustic emissions are shown to the right in (a) and (b). (a)
Examples of scattering at pressures above ADV threshold. (b) Four
examples of RF signals, for which 3.24 and 4.20 MPa are considered
below ADV threshold and 4.85 and 6.21 MPa are considered above
threshold. (c) Better illustrates the change in time-frequency plots
for waveforms in (b) when subtracting the spectra of the scattering
from the first 20 µs pulse. The time-frequency plot for 6.21 MPa is
not shown in (c) because there is no clear baseline spectrum because
IC is occurring during the entire pulse sequence. . . . . . . . . . . . 43
ix
2.8 Data points reflect the MEA of a given ROI through consecutive
frames in a B-mode cineloop. Statistics drawn from the mean MEA
of the baseline, defined here as the first nine data points, are used as
criteria for ADV detection. Pulses of the same amplitude are shown
on the top and illustrate the timing of the pulse firing during a given
cineloop. Frames associated with acoustic interference with the pas-
sive detector during pulse transmission are omitted (10, 11, 30, and
31). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44
2.9 Percentage of correct predictions made by a binary logistic regression
model for different criteria (number of SDs). Displayed on two differ-
ent scales are true negatives (no ADV) on the right ordinate and on
the left ordinate, true positive as well as an overall accuracy percent-
age (ADV, Overall). The maximum overall percentage is 91.7% when
using a criterion of five SDs above mean, meaning data and model
have the best agreement for this criterion. . . . . . . . . . . . . . . . 44
2.10 (a) Probability for ADV computed in the presence of 103 , 104 , and
105 microspheres/mL of Definity R© according to a criterion of five SD
above mean. Data at a given pressure amplitude show the result for
N = 10 or 20 measurements. The entire dataset, including results for
Pr > 2 MPa, is not shown in order to better display the transition of
probability from 0 to 1. Curve fits are taken from the regression model
described in the text. (b) The entire dataset for the experiments in
(a) is displayed here along with data that were collected with only
CA present (+), which show a higher threshold than the solutions
containing droplets. Data for (+) reflect N = 10 measurements. . . . 45
2.11 Frames immediately following acoustic interference are shown when
solutions containing both (a) droplets and CA and (b), (c) CA only
are exposed to 20 ms pulses. ADV occurs in (a) at 1.24 MPa as
indicated by the circle. At the same pressure, CAs are destroyed as
indicated by low echogenicity when droplets are absent (b). Increasing
the pressure to 5.46 MPa further causes high echoes in areas surround-
ing the focal zone, which may be the aggregation of CA microspheres
in the side lobes. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46
2.12 Probability results for ADV using 20 µs tone bursts. CA concentra-
tion is 105 microspheres/mL. Circles and diamonds are data collected
from ADV in flow conditions. The white vertical line and the gray
region indicate the mean ADV threshold in Pr with no CA present
and the associated standard error, respectively, found in the static
experiments using detection by B-mode cineloops. . . . . . . . . . . 47
x
3.1 a) Data from four different free water calibrations, where pressure was
measured with a fiber optic probe hydrophone. The data was fit with
a simulated curve derived from the KZK equation. b) For a given
pressure attained in a water path, the corresponding in situ pressure
from the same acoustic source achieved through an attenuating gel is
plotted. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 66
3.2 Axial beam profile with Zerdine R© insertion. Each data point indi-
cates the Pr at each location normalized to the maximum value of
the second degree polynomial fit (line). Position 1, or the spatial
maximum in a water path, is located at 0 mm. When the major-
ity of the water path was replaced with an attenuating medium, the
spatial maximum shifted approximately 1.5 mm (Position 2) toward
the transducer. The amplitude at Position 2 was only 2% greater
than that at Position 1 when the two locations were measured in the
presence of Zerdine R©. This ratio, however, increases with amplitude. 67
3.3 The Fourier transforms of two waveforms with an in situ Pr of 5.4
MPa. One waveform was measured in a water path, and the other
through a Zerdine R© TM phantom. . . . . . . . . . . . . . . . . . . . 68
3.4 REA vs. Pr curve for formulations of (a) droplets, where the associ-
ated curve fit is also plotted, (100 Hz PRF) and (b) droplets with CA
(10 Hz PRF). Both experiments were conducted in the absence of a
TM phantom. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 69
3.5 Example of REA/|REAmin| vs Pr curve for when droplets are mixed
with CA and for CA only. Both experiments were conducted in the
presence of a TM phantom. As such, Pr values are in situ. . . . . . . 70
3.6 Summary of threshold results. Results in terms of in situ Pr and
voltage applied to the transducer are in (a) and (b), respectively.
The IC threshold was measured with only saline, and in all other
measurements, the ADV threshold was measured. For the cases when
there were droplets and CA (D+CA) or only saline, the PRF was 20
Hz for a 16 cm/s flow rate; when only droplets were present, the PRF
was 100 Hz. For an 8 cm/s flow rate, a 10 Hz PRF was used. Error
bars indicate standard deviation. . . . . . . . . . . . . . . . . . . . . 71
3.7 a) Lines of pixels taken upstream of the focus, at the focus, and two
downstream of the focus are used to evaluate efficiency of ADV. This
single frame is taken from a B-mode movie capturing events during
an US exposure with 5.4 MPa Pr and 100 Hz PRF. b) The pixel
values in these lines are displayed. The lines positioned at the focus
and downstream of the focus show elevated pixel intensities when
compared to the upstream baseline position. . . . . . . . . . . . . . 73
xi
3.8 The pixels in each cross-sectional line were integrated and normalized
to the baseline, i.e. the integrated value of the line placed upstream
of the focus, to compute the efficiency factor. Thus, the efficiency
factor is the multiplicative factor of the baseline droplet echogenicity.
The efficiency factors for the focus, downstream, and downstream 2
positions are plotted against relative droplet concentration where a
value of 1 indicates a concentration of 2.85 x 106 droplets/mL. A flow
speed of 16 cm/s and an amplitude ∼40% higher (5.4 MPa Pr) than
the ADV threshold was used for the measurements shown here. Data
points represent single experiments in a given setup where the same
imaging plane was used. . . . . . . . . . . . . . . . . . . . . . . . . . 74
3.9 A comparison of the efficiency factor for varying PRFs for US expo-
sures at 5.4 MPa Pr. The same calculated droplet concentration of
2.85 x 106 droplets/mL were used for these measurements. No CA
were added. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 75
3.10 The efficiency factor for a range of amplitudes is plotted for US expo-
sure of a combination of droplets and CAs of the same concentration. 76
3.11 IM for sequential frames in a B-mode movie for (a) droplet and CA
and (b) droplets only. PRF for both US exposures was 100 Hz. (c)
shows IM values for a solution of droplets with CA for US exposures
of 10 Hz PRF. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 77
3.12 a) Collected data for ADV thresholds and theoretical predictions [12]
for inertial collapse for bubbles 10, 20, and 60 µm in diameter. (•)
are collected data from [14], (4) are from previous publications for
microsecond repetitive pulses [3][2]. b) Theoretical predictions for
inertial collapse for bubbles of a range of diameters for insonation at
1 MHz. Bubbles resulting from ADV span the range of 10-60 µm in
diameter [14]. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 82
4.1 18-element annular array with associated amplifier. . . . . . . . . . . 91
4.2 Calibration of the 18-element annular array with operating frequency
of 750 kHz and geometric focus of 10 cm. The data were fit with a
third order polynomial. This array is the therapy transducer used to
create bubble clouds. . . . . . . . . . . . . . . . . . . . . . . . . . . 92
4.3 Experimental setup. The schematic drawing in (a) shows a side
view of the arrangement for an ADV threshold experiment where
the phased array is used to detect droplets vaporized by the annu-
lar array. (b) shows a frontal view of the arrangement for creating
a bubble wall. After making a wall, the gel is then repositioned to
the configuration in (A) for further threshold experiments. The same
holder is used in both cases and is depicted in two views here. . . . . 93
xii
4.4 Examples of B-mode images taken from a 5 MHz phased array placed
in the center of the annular array. These images were used to char-
acterize bubble clouds as a function of rarefactional pressure. US
exposures for three different conditions (as labeled) are pictured here,
and the ROIs surrounding them (numbered 1-4) are defined by the
dotted lines. The pixels in each ROI were evaluated in terms of pixel
intensity and number of pixels per cloud. . . . . . . . . . . . . . . . 97
4.5 Histogram of the pixel intensity of four gels. Threshold was set at 0.67,
which is approximately two standard deviations above the mean pixel
intensity as indicated by 2 (mean) and → (two standard devations). 98
4.6 Experimental setup for the characterization of a bubble wall. The
annular transducer transmitted ∼15 µs pulses at a PRF of 200 Hz and
rarefactional pressure of ∼3 MPa. The echoes and the transmitted US
were received by the 5 MHz transducer and hydrophone, respectively.
A window in the vertical wall of the holder that was approximately
the size of the cross-sectional area of the gel allowed US transmission
through the gel. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 98
4.7 Optical images of bubble clouds generated with 200 pulses in 7.5%
polyacrylamide gels. (a) unfiltered droplets; (b) droplets filtered to
16 µm; (c) droplets filtered to 5 µm all at 9.8 MPa (rarefactional); (d)
14.7 MPa, droplets filtered to 5 µm. A discussion of the cloud shape
is included in the text. . . . . . . . . . . . . . . . . . . . . . . . . . 100
4.8 (left) Image of the cigar-shaped cloud generated by rarefactional pres-
sures of 9.8 MPa with 20 pulses, and (right) teardrop-shaped cloud
generated by 9.8 MPa with 1000 pulses. Droplets were unfiltered in
both cases. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 101
4.9 Both images show clouds generated by rarefactional pressures of 14.7
MPa with 200 US pulses propagating from the top of the photograph.
On the left, the focus of the annular array is positioned on a nominally
1 mm wall, where some leakage occurs. On the right, the focus is po-
sitioned past the wall, exposing the bubble wall to the lower prefocal
amplitudes, which are less likely to leak through the wall. . . . . . . 102
4.10 Optical photographs demonstrating the effects of a bubble wall cre-
ated in a gel with droplets filtered to 5 µm. Pressure amplitudes for
each exposure is the same for a given photograph and are stated as
follows: (A) 1 mm thick bubble wall, 9.8 MPa; (B) 2 mm thick wall,
9.8 MPa; (C) 2 mm thick wall, 14.7 MPa (D) 2 mm thick wall, 14.7
MPa. The numbers indicate the sequence of US exposures, where
the focus of the therapy array (annular transducer) is first translated
laterally from positions 1 to 2, and then axially from 2 to 3. The
direction of US propagation is from the top of all photographs. Lo-
cations labeled 1 correspond to exposures in the absence of a bubble
wall, those labeled “2 correspond to exposures focused past a wall,
and those labeled “3 correspond to exposures focused in front of a wall.103
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4.11 Plots of cloud size and intensity as a function of rarefactional pressure
for two droplet distributions. Data were taken from B-mode images
from a 5 MHz phased array, where the imaging and therapeutic planes
were aligned. Both size and intensity increase with pressure, indicat-
ing that the overall cloud size grows as well as the echogenicity. . . . 108
4.12 Results from experiments involving a prefocal bubble wall. The plot
in A shows data from focal ROIs with 16 µm filtered droplets, and B
and C show averaged data from focal and proximal ROIs, respectively,
with 5 µm droplets. B-mode images were taken from an on-axis 5
MHz phased array (axial view) and a 10 MHz linear array, where
the transverse plane was oriented parallel to the axis of the annular
array (coronal view). Data from the two imaging probes confirm
that the bubble wall can both reflect and consequently shield distally.
Data points illustrate the variability that can occur in bubble walls
and their resulting efficacy in serving as a shield, at least with high
pressure beams. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 109
4.13 Backscattered and transmitted signals from and through a ∼2 mm
thick bubble wall. The results are shown for two cases: (A, C) the
focus of the annular array is positioned at the bubble wall , and (B,
D) the focus is positioned approximately 1 cm past the bubble wall.
In the comparisons of the backscattered signals (A, B), bright regions
indicate high backscatter, and in the comparison of the transmitted
signals (C, D), bright regions indicate high transmission. Signals in
dB are calculated relative to the backscattered and transmitted sig-
nals from a gel with no bubble wall. The top sidebar indicating the
dB scale corresponds to backscattered signals (A, B), and the bottom
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ABSTRACT
ACOUSTIC DROPLET VAPORIZATION: STRATEGIES FOR CONTROL OF




Chair: J. Brian Fowlkes
As a minimally invasive alternative to current cancer treatment, the use of
encapsulated, superheated liquid perfluorocarbon droplets has been proposed to
treat cancer by occlusion therapy. In response to an applied acoustic field, these
droplets, which are small enough to pass through capillaries, vaporize into large
gas bubbles that subsequently lodge in the vasculature. This research investigates
strategies to reduce the required pressures necessary to achieve acoustic droplet
vaporization (ADV), what implications they may have on efficiency, and how the
resulting location of bubbles may alter the acoustic field.
Two methods to lower the ADV threshold were explored. The first method
investigated the role of pulse duration on ADV. The second investigated the role of
inertial cavitation (IC) external to a droplet by adding ultrasound contrast agent
(CA), which has a low IC threshold. At 1.44 MHz, the threshold was found to
xvi
be 5.5-5.9 MPa peak rarefactional pressure (Pr) for short microsecond pulses and
decreased for millisecond pulses to 3.8-4.6 MPa Pr. When CAs were added and long
millisecond pulses were used, the ADV threshold decreased to values as low as 0.41
MPa Pr.
With the help of CA, the same amount of power was necessary to achieve
ADV through an attenuating tissue mimicking (TM) phantom as it was without
attenuation and with only droplets. When comparing ADV pressure thresholds,
where in situ pressures were used when a TM phantom was present, rarefactional
pressure appeared to be the salient determinant. However, careful consideration
must be taken when choosing pulse repetition frequencies and amplitude as inertial
collapse of both ADV and IC bubbles appears to affect efficient droplet conversion.
During in vivo application, treatment planning may be important as backscat-
tering properties of microbubbles created by ADV can augment or obstruct the
sound field in the affected area. With strategic targeting and subsequent conversion
of droplets into microbubbles at one location, constructive interference due to these
effects reduces the transmitted pressures required for ADV proximal to that location.
The attenuation from these bubbles can create a protective boundary for areas distal
to the treatment volume. The potential result can be a confined area for further





1.1 Minimally Invasive Surgery
Minimally invasive surgery (MIS) has long since been a movement in the practice
of medicine. With minimal collateral damage, it is a natural progression as less
damage to overlying tissue minimizes chances of infection, facilitates healing, and
reduces scarring, all of which reduce the possible accompanying costs of the surgery
itself. Currently, MIS practice is often considered laparoscopic or endoscopic surgery,
where small incisions are made for insertion of a camera and long surgical instruments
into the body. In a less traditional sense although in no way less established, MIS
also includes extracorporeal treatments that have been developed to perform surgery
without the need of any incision. Examples include shockwave lithotripsy and now,
high intensity ultrasound (US), which has become a new wave of minimally invasive
or perhaps even noninvasive techniques to perform surgery.
This chapter will provide an overview of the current available technologies for
minimally invasive and noninvasive surgery. Of particular interest is the treatment
of renal cell carcinoma (RCC), where unique challenges arise due to the location of
the organ and its high perfusion. A discussion of the current techniques and their
challenges as they apply to RCC is provided and is followed by the introduction of
the thesis topic. This dissertation will describe research into a novel cancer therapy
technique that creates gas emboli to deprive cancer cells of their blood supply. This
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technique uses injectable liquid dispersions that can be vaporized with an acoustic
pulse at a specific target. In comparison to the available alternatives, this method
offers advantages that make it more ideal for treatment of RCC.
1.2 History and Future of Surgical Techniques
1.2.1 Laparoscopy and Endoscopy
With the important benefits reaped from MIS, many advances and innovations
were achieved in a short amount of time. The first laparoscopic cholecystectomy
(gall bladder removal) was performed in France in 1987 by Mouret, and in one
year had spread to the United States and other countries [1]. It became the
standard method of treatment [2] in two years. Around the same time, the
United States Army funded the former Stanford Research Institute to produce a
telesurgical workstation for remote surgery on the battlefield. The outcome from
this project became the prototype for the now commercial da Vinci R© Surgical
System (Intuitive Surgical, Inc., Sunnyvale, CA), which was first cleared by the
United States Food and Drug Administration (FDA) in 2000 for general laparoscopic
surgery. It is currently approved by the FDA to perform certain minimally
invasive urologic, gynecologic, and cardiac surgical procedures. Mitral valve repairs,
joint replacements, prostatectomies, and other surgeries are now performed with
laparoscopic or endoscopic minimally invasive techniques on a regular basis.
Extending the idea to telesurgery, then, does not seem out of reach. With the
capabilities of information technnology (IT) today, the global reach of medicine is
broadened in what has been dubbed “telemedicine”. In the future, surgeons would
be able to extend their technical skill set beyond their own operating room. Because
it is already possible to perform surgery without being in direct contact with a
patient with current commercial systems, these surgical techniques should also be
able to be translated offsite through the use of telecommunications. Research is
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being done to develop these telesurgical workstations, where surgeons perform the
procedure in a remote location while being given the appropriate visual cues. Their
motions and commands are transmitted to the robotic workstation where the patient
is situated. Assistants present in the operating room are responsible for changing
surgical tools as well as following instructions given by the offsite surgeon. With
telecommunications, the potential of this system is global. Experts from all over the
world can work together in a remote operating room. This not only brings together
the best talent to one room, but it also saves resources in air travel and time, and can
be beneficial to the patient who is perhaps too sick to travel. This is telemedicine at
its highest level.
Current implementation of telemedicine allows doctors to share medical
knowledge on a global level. Today, physicians in certain African nations can extend
outside their borders to reach specialists for medical consultations in countries
such as Canada and the United States [3]. Thus, patients traveling to their local
facilities are assured that they will receive world-class care, an attractive service
that encourages more consumers to seek medical attention. Existing collaborations
include King Faisial Specialist Hospital and Research Center in Saudi Arabia and
Massachusetts General hospital, Singapore General Hospital and Stanford University
Hospital, King Hussein Medical Center in Jordan and Amman Surgical Hospital with
the Mayo Clinic, and Arab Gulf States with WorldCare, a private U.S. company [3].
1.2.2 Bloodless Alternatives
Apart from the burgeoning utility that laparoscopic techniques have found in
robotics and telemedicine, bloodless surgery has also been in practice for a number
of years. Some of these technologies are listed and described in the following section.
Extracorporeal shock wave lithotripsy (ESWL) as a treatment of kidney stones
was introduced in 1979 in Germany [4], with the first human clinical trial in 1980
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by the same group [5]. Ultrasound (US) had been used prior to ESWL, but direct
contact between stone and transducer was necessary. Shock waves in ESWL are
generated by spark electrodes placed in one geometric focus of half an elliptical
reflector and refocus to the second focus of the ellipse, where the target (kidney










Figure 1.1: Current available minimally invasive or extracorporeal treatments. (a)
A schematic of the extracorporeal shock wave lithotripter designed by [6]. (b) An
example of cryoablation of an exophytic renal tumor, where two cyroprobes are labeled
along with an US probe for real-time monitoring. Adapted from [7]. (c) As seen in this
frontal angiogram, an RF probe with deployed hooks, as illustrated by long arrows,
is inserted into the nodule of a hepatocellular carcinoma. Blood flow is occluded with
a balloon catheter (short arrow) in the hepatic artery [8]. (d) shows the Model JC
Haifu system (Chongqing Haifu Technology Co., Ltd., Chongqing, China) used for
HIFU treatment [9]. Images were collected from the above cited references.
Among the oldest therapies, cryoablation was conceptually introduced in 1850
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[10] and works by freezing (freeze cycle of the freeze/thaw protocol) the target area
via a vacuum-insulated cryoprobe tip circulated with liquid nitrogen. The freeze
must lower the tissue temperature to -40 to -50◦C [11] to ensure complete cell death.
In order to treat the entire volume, the portion of the cryoablated lesion, or “iceball”
(Fig. 1.1b), at or below the required temperatures must reach the borders of the
tumor. Gill et al. [12] extended the iceball to 1 cm beyond each of the 11 tumors
included in the study with positive results, though all tumors were small, peripheral,
and exophytic. When circulation is restored (thaw cycle), damaged blood vessels
caused by the freeze result in edema, vascular occlusion, and thrombosis [7]. Further
complications include cracking and bleeding of the renal parenchyma during the
thaw phase, which is often mediated with various occlusion methods to achieve
hemostasis. Nevertheless, cyroablation has been shown to be relatively effective and
safe [7].
Radiofrequency ablation (RFA), which heats tissue to coagulative necrosis, has
been in existence since the early 1990s [13], and has shown promise in treatment of
hepatocellular carcinoma (HCC), prostate tumors, and breast tumors. RFA involves
a percutaneous needle electrode that is inserted into the tumor (Fig. 1.1c) under
the guidance of computed tomography (CT) or US. Current flow generated from the
electrode deposits RF energy over the immediately surrounding tissue and creates a
thermal lesion, which in time results in irreversible cell death [14]. Power ranges from
26-50 W, and frequencies range from 460-500 kHz [7]. High impedances, however,
can be caused by tissue desiccation during treatment and limits the size of the
lesion. Polascik et al. [15] found that they could also achieve time-dependent and
predictably sized lesions in lepus kidneys using a cool-tipped system, where saline
was used to couple the electrode to the tissue. Saline was continually infused during
treatment, preventing tissue desiccation and consequently, preventing increases in
impedance in tissues immediately surrounding the electrode. The RF energy could
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then conduct further away without being depleted in high impedance zones.
Focused ultrasound was introduced for therapeutic purposes in the late 1940s
[16]. On a global scale, high intensity focused ultrasound (HIFU) is now becoming a
well-established clinical method of bloodless noninvasive surgery as US can penetrate
through tissue and raise the temperatures in a tight focal region in excess of 56◦C
[17]. This degree of thermal dosage causes coagulative necrosis and cell death in an
area limited by the focal size of the beam. Spatial peak pulse average intensities
(ISPPA) range from 1500-2500 W/cm
2 , and duty cycles are normally greater than
50% with pulse durations lasting several seconds. The delineation between healthy
and dead cells are on the order of six to ten cells [18][19]. Commercialized units in
current clinical use for extracorporeal therapy include the Model JC Haifu system
(Fig. 1.1d) from Chongqing Haifu Technology Co., Ltd. (China), ExAblate R©
2000 from Insightec, Ltd. (Israel), and the HIFUNIT-9000 from Shanghai A&S
Science Technology Develoment Co., Ltd. (China). Applications are numerous and
promising, including HCC, uterine fibroids, breast cancer, prostate cancer, bone
tumors, and pancreatic carcinoma. Additionally, it can be used for hemostasis to
seal blood vessels and prevent excess bleeding in open invasive surgeries [20].
In the United States, companies developing extracorporeal therapeutic ultrasound
devices for specific indications have emerged. A few are approved for commercial
use by the FDA such as the Sonotherm 600 Ultrasonic Lesion Generating System
(Focus Surgery, Inc., Indianapolis, IN) and ExAblate R© 2000 (Insightec, Ltd., Israel)
for uterine fibroids, but many are in human clinical trials or are approved for use in
Europe, Australia, and/or Asia. The first HIFU device approved by the FDA was
Sonocare CST-100 Therapeutic Ultrasound System (Sonocare, Inc.) in 1980 and was
designed for the treatment of glaucoma. However, the system became outdated by
the dominance of laser surgery.
Histotripsy [21], a technology emerging from the University of Michigan, takes
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a different route in therapeutic US. Focused US in this case uses low duty cycles
and high intensities (≥9000 W/cm2 ISPPA). Instead of converting ultrasonic energy
into heat energy, the chief mechanism takes advantage of the mechanical forces
produced by inertial cavitation. The human body is almost devoid of cavitation
nuclei, necessitating the use of high intensities; however, histotripsy does not cause
thermal leasions, but rather, tissue fractionation. It was found that the temperature
rise in ex vivo porcine kidneys only increased 6-10◦C at the focus [22]. The lesions
are repeatable, controllable, and well-defined, where the border of the destruction
zones can be on the order of a single cell [23] to delineate live cells from tissue
homogenate.
1.3 Renal Cell Carcinoma
The technologies mentioned in the previous sections have been well documented
for implementation in the breast, prostate, liver, heart, bone, uterus, and pancreas.
However, the kidney is unlike other target applications in its location within the
body and its high vascularity (Table 1.1). This section will provide an overview
of current methods of treatment for renal cell carcinoma (RCC) along with their
implications and then introduce a novel method that can circumvent the challenges
confronting other therapies.









Table is reproduced from [24].
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1.3.1 Current Treatments
The National Cancer Institute estimated that about 51,190 new cases of kidney
cancer would arise in 2007 in the United States with an estimated 12,890 total deaths
[25]. This incidence of kidney cancer is an increase of 30% from the estimate given
for 2006, although the total number of estimated deaths has remained relatively
unchanged [26]. RCC accounts for 80-85% of the cases of kidney cancer and
has a five-year survival rate of 65% after diagnosis; however, when caught before
metastasis, the prognosis improves to a 90% five-year survival [26]. The standard
treatment for RCC was initially open radical nephrectomy for containment of the
cancer, but it was later shown that there was no significant change in cancer survival
for patients who underwent radical nephrectomy versus partial nephrectomy [27].
With no notable disadvantage in terms of cancer treatment, nephron sparing surgery
became very desirable because it also considerably reduced the number of cases of
renal insufficiency.
Thus, present day treatment for RCC attempts to preserve kidney function
if possible and can use minimally invasive techniques such as cryoablation, RFA,
microwave and laser thermotherapy, and laparoscopic partial nephrectomies, which
are likely to eventually replace conventional open surgery [28]. Two-thirds of new
RCC occurrences that are detected while asymptomatic as a result of the improved
imaging, half of which are <3 cm [29], have enabled early treatment and improved
diagnosis. Because the detectable masses are small, the growth rate of RCCs are
slow (0.35 cm/year) [30], and diagnosis is frequently among older patients [29], MIS
has been investigated as the preferred mode of treatment. Despite the advantages
garnered by MIS, laparoscopic partial nephrectomies are still associated with high
morbidity, and other techniques in current clinical use require percutaneous access
to the organ and are confined to RCCs no larger than 3 to 4 cm in diameter [31].
These small RCC masses treatable by minimally invasive means would be
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appropriate for the size of tumors that are detected in their early stage, but
treatment still appears unreliable. In a 3.5 year study of RFA treatment of kidney
tumors [13], 36 of the 42 ablated tumors were treated to technical success, which was
defined as the absence of tumor enhancement in postoperative magnetic resonance
or computed tomography images taken one month after the ablation study. The
most successful cases in the study by Gervais et al., though, involved RF ablation
of exophytic or parenchymal tumors. Those extending into renal sinus fat had a
much lower success rate of 45% of the 11 cases versus 100% of the 31 exophytic or
parenchymal cases. Many blood vessels flow near the renal sinus and serve as a heat
sink, which limits the maximum achievable temperature and/or the target volume
[32]. The resulting lesions are unpredictable in shape and volume, depending on the
vascular structure surrounding the tumor.
Cryoablation likewise is confined to small tumors, where larger tumors (>2.5 cm
in diameter) may require multiple probes. Despite the success in peripheral and
exophytic tumors, tumors deep within the kidney require intrarenal probe placement
[33]. It was hypothesized that the cold temperature was dissipated by blood flow
[12], but occlusion of the renal artery during cryoablation did not appear to produce
any significantly different results [33].
Extracorporeal treatment of the kidney has also proven to be a challenge. HIFU,
which has shown success for other indications such as breast or prostate cancer, faces
different obstacles for the kidney, which is situated near the ribs, bowel, and lungs,
moves with respiration, and is highly perfused [34][35]. With optimization, HIFU in
the kidney may prove efficacious, as certain studies have been successful; however, the
impact of ablation on the promotion of metastasis due to cell mobilization remains
controversial [34]. Minor complications can include skin burns and hematuria, but
treatment time and total treatment coverage may still be the larger challenges.
Finally, histotripsy would avoid the problems associated with the “heat sink.”
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Since the therapy is not related to heat but instead mechanical disruption, it
could prove to be a viable treatment method. While some initial results show that
histotripsy does not damage larger vessels, the treatment does disrupt capillaries,
which causes minor hemorrhaging thought to be clinically insignificant. Histotripsy
research is ongoing, and studies are now being conducted with promising results to
evaluate the efficacy of histotripsy in the kidney.
1.3.2 Embolotherapy
Embolotherapy, which is the process of occluding blood flow for therapeutic
purposes, can also be used to treat tumors by obstructing the feeder arteries that
supply the tumor, thereby inducing ischemia and eventually necrosis [36][37][38].
Vascular embolization was first proposed in 1904 by Dawbain [37] and was executed
later in 1960 [39] when embolization of the common carotid artery was performed
with positive outcome for a patient with an arteriovenous malformation in the brain.
Due to reduced peripheral resistance of the arterial feeders, blood flowed favorably
to the malformation [40]; normal blood flow was restored following occlusion of these
feeder arteries. Interest in embolotherapy then escalated in 1963 when hemorrhage
rates of 0.5 mL/min became detectable [41] with improved imaging, enabling early
treatment by means of transcatheter embolization [42]. Advancements in catheter
technology and imaging coincided with advancements in occlusion agents in the
1970s, spurring a movement for embolotherapy in interventional radiology [37].
Current Agents and Applications
The current method for embolization involves catherization and placement of
occlusion agents in the area of interest. Occlusion agents include metallic microcoils
(stainless steel, tungsten, or platinum), acrylic microspheres (embospheres),
polyvinyl alcohol particles (PVA), absolute ethanol, and Gelfoam (Pharmacia &
Upjohn, Kalamazoo, MI) [43]. Embospheres, which are becoming the preferred
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agent, are made from a trisacryl polymer matrix combined with porcine gelatin
and are uniform in size to prevent clogging in the catheter. PVA, which have been
used since the 1970s are 300-700 µm foam particles, where size varies for different
indications. Gelfoam is also made of foam, though they are absorbable and only a
temporary occlusion agent. Microcoils [44] and ethanol [45] promote clot formation.
Schwartz et al. [43] gathered data over a 12-year span beginning in 1993 and
conducted a retrospective study on renal patients who underwent embolotherapy.
From the 121 cases examined, 54.5% had renal artery embolization preceding
nephrectomy of their renal masses. These data were collected only within the Weill
Medical College of Cornell University (New York, New York) and the popularity of
the procedure may be confined to this institution [46]. Nevertheless, it was found
that embolized patients experienced less blood loss during resection as well as a
reduction in preoperative size and level of tumor thrombus. Controversy pertaining
to the necessity of post-embolization nephrectomy remains as the study by Schwartz
et al. [43] cites work done by other groups [47] [48], who found no survival benefit
when renal artery embolization for metastatic RCC was or was not followed by
partial nephrectomy.
Embolotherapy for palliation [37] and to maintain hemostasis due to associated
metastases with RCC, however, is common [46][43][49][50]. Emergent traumatic
gastrointestinal hemorrhage [51][52][53] as well as obstetric and vascular conditions
[54] are among other indications treatable by transcatheter embolization. However,
the efficacy of preoperative embolization remains debatable for vascular tumors, as
opposing data is found in the literature [54][37]. It is maintained that treatment
plans must be patient-based.
Postembolization Syndrome
A common complication resulting from occlusion therapy is postembolization
syndrome (PES), which is marked by fever, nausea, vomiting, and flank pain. From
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a compiled list generated from the literature comprising 55 patients who were treated
for angiomyolipomas, or benign hamartomatous tumors, PES was found to occur in
89% [55] of them. It is thought that PES occurs because of the body’s inflammatory
response to the necrotic tissue caused by embolization. Symptoms resolve in 1-10
days [55][37] and has in the past been treated with analgesics, but PES can be severe
for some patients. Hormone treatment appears to alleviate the effects of PES [55].
1.3.3 Embolotherapy by Acoustic Droplet Vaporization
A novel method to perform embolotherapy was introduced by [56], which provides
the groundwork for this dissertation. The work in [56] developed upon a patented
concept [57], where a liquid perfluorocarbon (PFC) droplet becomes superheated
when placed in an environment above the bulk boiling point of the PFC. This droplet
contains a PFC liquid core and is encased in an albumin shell. The shell serves as
a stabilizer and prevents evaporation, allowing the droplet to remain stable until
perturbed by the environment, when it is subject to vaporization; thus, these droplets
are described in [57] as “activatable infusable dispersions.” Its activation into a gas
bubble in response to an acoustic field is termed acoustic droplet vaporization, or
ADV. These droplets expand into gas bubbles that are 5-6 times larger in diameter
than the initial droplet [58], and if this were to occur in a capillary, these bubbles
would lodge, effectively occluding the blood vessel [59].
In its proposed application for embolotherapy, the process would be entirely
extracorporeal. The feeder arteries to the tumor would first be identified and targeted
for insonation by a therapeutic transducer. B-mode US by a separate imaging
transducer would be aligned with the focus of the therapeutic transducer to provide
feedback for correct alignment and successful ADV. For the intended treatment of
RCC, current studies have targeted the renal artery [60], but with adequate imaging
and careful positioning, segmental arteries isolating different poles of the kidney
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should be achievable. Droplets would then be injected intravenously and then
insonified once they reached the targeted vessel, where they would subsequently
vaporize. This process would continue until occlusion was accomplished. Further
therapy could also be achieved when droplets are loaded with potent drugs that
would then be locally delivered to the occluded site.
Embolotherapy by ADV can be both extracorporeal and minimally invasive,
making it an improvement over current treatments including cryoablation, RF
ablation, and transcatheter embolization. Additionally, the treatment is not subject
to the problem of the “heat sink,” but instead, uses blood flow to its advantage.
In fact, ADV can be used as an adjunct to current therapies such as cryoablation,
RF ablation, and HIFU by temporarily introducing an embolus to reduce heat
dissipation caused by perfusion. In a study combining RFA and balloon catheter
embolization (pictured in Fig. 1.1c) [8], lesions ranging from 3.5-5.5 cm in diameter
were attained. The maximum lesion diameter was 2.5 cm without embolization in
a previous study using the same electrode and technique [61]. Another challenge
posed by the kidney, as mentioned previously, is its vulnerability to movement due
to respiration. The required amplitude and time-averaged power (30-1200 W/cm2
ISPPA, 0.3-1.2 W/cm
2 spatial peak temporal average intensity, ISPTA) necessary to
achieve ADV are much lower than those required for HIFU or histotripsy, which
allows for movement during treatment without the risk of damaging other tissues.
1.4 Overview of Dissertation
The following chapters will take an in-depth look at the strategies that can be
used to reduce the input energy required to accomplish in vivo and transcutaneous
ADV and how the resulting bubbles might by utilized to achieve therapeutic results.
Each of the chapters in this dissertation contains appropriate background material
for the addressed subject and can therefore be read independently of each other. An
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overview of the chapters is outlined below.
Since the intended treatment via ADV is extracorporeal, it is important to
counteract the effects of attenuation. It was found that pressure threshold required
to induce ADV is inversely related to frequency [62]; however, to be able to penetrate
through several centimeters of tissue, a low frequency is optimal. All studies
presented in this thesis therefore work in this low frequency regime (750 kHz to 1.5
MHz).
Chapter II focuses on strategies to reduce the ADV threshold. Previous studies
[60] have concentrated on high frequencies (3.5 MHz) for proof of principle in small
animal models. Full comprehension of the mechanisms involved in ADV has not yet
been understood, but the findings in Chapter II elucidate in part the contributors in
the process. Appropriate citations for the material in this chapter are:
• A.H. Lo, O.D. Kripfgans, P.L. Carson, and J.B. Fowlkes. ”The Effect of Pulse
Length on Acoustic Droplet Vaporization.” Proceedings IEEE Ultrasonics
Symposium, pp. 285-286, 2006.
• A.H. Lo, O.D. Kripfgans, P.L. Carson, and J.B. Fowlkes. ”Acoustic
Droplet Vaporization Threshold: Effects of Ultrasound Contrast Agent and
Attenuation.” Proceedings of the 7th International Symposium on Therapeutic
Ultrasound, 2007.
• A.H. Lo, O.D. Kripfgans, P.L. Carson, E.D. Rothman, and J.B. Fowlkes.
”Acoustic Droplet Vaporization Threshold: Effects of Pulse Duration and
Contrast Agent.” IEEE Transactions on Ultrasonics, Ferroelectrics, and
Frequency Control, 54(5): 933-946, 2007.
These strategies were then translated to an experimental setup that simulated
in vivo conditions, where an overlying tissue-mimicking phantom attenuated the
applied US field. Chapter III discusses efficiency issues in the application of ADV
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to in vivo conditions. A portion of the material in this chapter is published in the
following proceedings article:
• A.H. Lo, O.D. Kripfgans, P.L. Carson, and J.B. Fowlkes. ”Acoustic
Droplet Vaporization Threshold: Effects of Ultrasound Contrast Agent and
Attenuation.” Proceedings of the 7th International Symposium on Therapeutic
Ultrasound, 2007.
Chapter IV explores the potential of the resulting lodged bubbles to alter
the acoustic field and explores the applications that the altered field may have.
Microbubbles scatter ultrasonic energy, a characteristic that has been employed
in the form of ultrasound contrast agents. The larger bubbles created by ADV
behave similarly, and their effects can be manipulated for therapeutic purposes. The
material in this chapter is published in the following article:
• A.H. Lo, O.D. Kripfgans, P.L. Carson, and J.B. Fowlkes. ”Spatial Control of
Gas Bubbles and their Effects on Acoustic Fields.” Ultrasound in Medicine
and Biology, 32(1): 95-106, 2006.
Finally, Chapter V provides a summary of the findings in the previous
chapters and explores ideas for continuation of this work. Future experiments for
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CHAPTER II
Acoustic Droplet Vaporization Threshold: Effects
of Pulse Duration and Contrast Agent
2.1 Introduction
Embolotherapy describes the obstruction of blood flow in the vasculature, which
is caused intentionally for therapeutic purposes. It is currently used in hemorrhage
control and has potential utility in cancer therapy, either as an occlusive treatment to
effect tissue infarction [1] or in the future, as an adjunct to current treatments such as
radiofrequency ablation. A possible implementation of embolotherapy was patented
by Apfel et al. [2], who suggested the use of superheated immiscible liquid droplets.
Variations of such droplets have already been evaluated as potential ultrasound
contrast agents [3], where sub-micron sized droplets of liquid perfluorocarbon (PFC)
were in part vaporized prior to injection into the body [4]. Another formulation
of droplets presented as embolotherapy agents for acoustic droplet vaporization
(ADV) [5] are larger in size (1-10 µm). Injected into the body as stabilized liquid
emulsions, they vaporize in response to an acoustic field into gas bubbles that are
five to size times [5] larger in diameter than that of the original droplet. ADV has
been successfully shown in vivo to produce gas emboli and reduce blood flow [6].
Embolization by ADV is advantageous because it can potentially be performed
transcutaneously with essentially no damage outside the treatment region. However,
the applied ultrasound must be able to overcome attenuation from tissue when the
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target is deep inside the body. Low frequencies are advantageous to reduce the effects
of attenuation, which should increase the range of depths and available aperture at
which ADV can be accomplished. However, previous studies have shown that the
pressures required to produce ADV increase with decreasing frequency [7]. Although
the application is therapeutic and the bioeffects of high amplitude exposure perhaps
an acceptable consequence, it remains favorable to minimize the amplitudes required
to produce the desired effect for the robustness of the technique and from the patient
and the logistic perspective. Hardware necessary to generate high pressures may be
expensive and/or large for feasible use in the operating room.
In order to use low frequency ultrasound, other parameters may be changed
to lower the ADV threshold. It may be possible that inertial cavitation (IC) is
linked to ADV, in which case the opposite relationship would exist. Since IC
threshold decreases with decreasing frequency, ADV threshold may also lower at
a low frequency when droplets are associated with IC. Giesecke et al. [8] showed
that the IC threshold in the presence of various PFC droplets is indeed lower at low
frequencies when using long millisecond pulses. The use of long pulses may also be
advantageous because IC is a stochastic process, and the probability that IC occurs
increases the longer ultrasound is applied [9].
This study investigates the effects of pulse duration and IC on ADV. The
pressures required to induce each phenomenon were found for ultrasound exposures
of microsecond to millisecond pulse durations at a low frequency of 1.44 MHz.
Additionally, contrast agents (CAs), which have a low IC threshold, may lower
the ADV threshold if in fact the two processes are linked. Therefore, a second
experiment measures the ADV threshold when the droplets are in the presence of
CAs.
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2.2 Materials and Methods
Experiments investigating the effects of pulse duration on ADV threshold and
ADV in the presence of CA were conducted in both a static environment and in flow.
Table 2.1 summarizes the experimental conditions, including acoustic parameters
and method of detection for ADV or IC. Details are described subsequently in this
section.
Table 2.1: Summary of Experimental Conditions
Experimental
Condition
Pulse Duration Study Contrast Agent Study
[cm/s]





Pulse seq.: single 20 µs -
20 ms tone bursts, multiple
pulses
Pulse seq.: single 20 ms tone
bursts
Flow Agents : droplets Agents : droplets and CA
Detection: B-mode Detection: B-mode
Pulse seq.: single 20 µs tone
bursts
Pulse seq.: single 20 µs - 20
ms tone bursts
*Control : CA only, 20 ms
Pulse duration experiments examined the ADV threshold when only droplets were present. CA
experiments examined the threshold when both droplets and CA were present. A control experiment
in which only CAs were exposed to 20 ms tone bursts also is listed.
2.2.1 PFC Droplets
As described in [5], dodecafluoropentane (DDFP) (09-6182, Strem Chemicals,
Inc., Newburyport, MA) was combined with a 4 mg bovine albumin (A3803,
Sigma-Aldrich, St. Louis, MO) /mL saline solution. The mixture was then shaken
for 30 s in a vial mixer (Vialmix, DuPont, Billerica, MA) for droplet emulsification,
where the DDFP liquid droplets become encased in albumin shells. The DDFP
droplet will remain as a liquid at room temperature and, although DDFP has a
boiling point of 29◦C, will remain a liquid even at body temperature at 37◦C.
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At 37◦C, DDFP is a superheated liquid that is stabilized against spontaneous
evaporation due partially to the albumin shell [5]. All solutions of droplets were
pushed through a series of syringe filters (Whatman, Maidstone, UK) so that the
maximum droplet diameter was 6 µm [6] in order to accommodate in vivo conditions,
where droplets must be able to pass through capillaries. A droplet concentration (as
determined from samples counted using a hemacytometer imaged under microscopy)
of approximately 5.3x107 droplets/mL was used in all experiments by diluting the
stock droplet solution in de-ionized water. The dilution was then stored in the
refrigerator between experiments.
2.2.2 Contrast Agent
In the CA experiments, various concentrations of Definity R© contrast agent (Bristol-
Myers Squibb Medical Imaging, North Billerica, MA), which are microbubbles
consisting of PFC gas in phospholipid shells, were added to solutions with the same
concentration of droplet as mentioned above. The concentrations that were used
were 103, 104, or 105 microspheres/mL and were determined according to appropriate
dilutions of the concentration of Definity R© specified in the package insert. Vials of
Definity R© were activated several days prior to the experiments and were re-used for
separate measurements. PFC gas replaced the headspace as Definity R© was aspirated
from the vial for each experiment. Unless otherwise specified, further mention of CA
will refer to the use of Definity R©.
2.2.3 Acoustics
Single tone bursts of 20 µs, 100 µs, 500 µs, 1 ms, 5 ms, 10 ms, and 20 ms
in duration and 1000 tone bursts (20 µs each in duration) at a pulse repetition
frequency (PRF) of 500 Hz were transmitted at a carrier frequency of 1.44 MHz
with an annular transducer (63 mm focal length, 63.5 mm aperture in diameter, 63.5
mm radius of curvature, Etalon 940501, Lebanon, IN). Pressure waveforms at the
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spatial peak of the annular transducer were calibrated with an in-house fiber-optic
probe hydrophone [10]. Pressure levels ranged from ambient pressure to 6 MPa peak
rarefactional pressure (Pr).
To achieve the long pulse durations used in these experiments, a master function
generator (Hewlett Packard 33120A, Palo Alto, CA) gated a second slave function
generator (Hewlett Packard 3314A, Palo Alto, CA). The slave function generator
then output a 1.44 MHz sinusoid to an amplifier (ENI A300, Rochester, NY),
which was then sent to the annular transducer. The master function generator also
triggered the appropriate detector to begin recording data.
The purpose of the first set of experiments was to explore the effect of pulse
duration on ADV threshold; thus, all pulsing parameters described above were
measured. In the second set of experiments, which explored the influence of CAs on
ADV, only single 20 µs and 20 ms tone bursts were used.
2.2.4 Experimental Setup for Static Experiments
The focus of the annular transducer was positioned inside a closed vessel made of
thin-walled dialysis tubing (5 mm diameter, Spectra/Por R©, Spectrum Laboratories
Inc., Laguna Hills, CA), which was replenished with a new solution of droplets or
droplets with CA between each threshold measurement. A piece of sound absorbing
rubber (SOAB, BF Goodrich, Jacksonville, FL) was placed at an angle on the
distal side of the tube to minimize reflection and the possibility of standing waves.
Experiments were performed in 37◦C de-ionized water (Ex 7, ThermoNESLAB,
Newington, NH). A schematic of the setup is shown in Fig. 2.1a.
Two methods of detection were used, although not concurrently in the actual
experiment (Fig. 2.1b). One of these methods used a diagnostic ultrasound imaging
system (Diasonics VST Series, Milpitas, CA) with a 10 MHz linear array positioned
approximately 30◦ from the annular transducer, to record B-mode images for
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(a) (b)
Figure 2.1: (a) Top view of the experimental setup for measurements performed
in a static environment. The therapeutic transducer and the associated electronics
necessary to create millisecond pulses are shown. Both methods of detection also
are illustrated and labeled as Detector 1 and Detector 2, though they were not used
concurrently. (b) Schematic (side view) of the experimental setup used in studies
measuring ADV threshold in the presence of contrast agents in a flow environment.
Solutions contained either droplets, droplets and 103, 104, or 105 microspheres/mL
of Definity R©, or 105 microspheres/mL of Definity R©. Experiments were performed in
37◦C deionized water.
27
detection of bright echoes from large bubbles created by ADV. The second method
was to detect the acoustic emissions from IC, which was achieved with a passive
5 MHz single element transducer (Valpey-Fisher, Hopkinton, MA), positioned 90◦
from and confocal with the annular transducer. An oscilloscope (Lecroy 9310L,
Chestnut Ridge, NY) was triggered with each transmitted pulse and captured the
radiofrequency (RF) signals associated with any acoustic emission or scattering. The
detectors were positioned as mentioned previously to minimize interference from the
direct wave of the annular transducer. Similarly, because of acoustic interference
from the linear array, the two detectors were used separately.
Each ADV threshold measurement was conducted as follows. A new sample was
loaded into the closed vessel, leaving space at the top for gas expansion. The vessel
was then connected to a holder, which oriented the vessel vertically and positioned
it so that it coincided with the focus of the annular transducer. Single tone bursts
or multiple tone bursts were then transmitted from the annular transducer 10-25 s
apart (depending on the pulse duration) with increasing pressure amplitudes. This
process was repeated five times for each acoustic parameter.
Once ADV threshold was reached, subsequent measurements at higher pressures
were affected since lingering bubbles from the previous pulse facilitated further
ADV. Vaporized droplets provided additional cavitation nuclei in the acoustic field
of subsequent pulses if they adhered to the tube wall or if enough bubbles were
produced that they could not clear the beam before the next pulse. Since we were
only concerned with measuring the ADV threshold, the interference from remaining
bubbles with successive pulses at super-threshold amplitudes did not affect the
determined threshold.
Table 2.1 shows that both solutions (droplets and droplets with CA) were
performed in a static environment. The majority of pulse duration experiments
involving only droplets were performed in a static environment, though a limited
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number of experiments were performed in flow for a comparison of the two
environments. However, a static environment is not optimal when CAs are present
because it is difficult to achieve a homogeneous distribution of CA and droplets due
to a difference in buoyancy. Therefore, only a limited number of experiments with
CA and droplets were performed in a static environment.
2.2.5 Experimental Setup for ADV in Flow
The circulating flow system is shown in Fig. 2.1b. A solution of droplets (5.3x107
droplets/mL), droplets and CAs (103, 104, or 105 microspheres/mL), or CA only
(105 microspheres/mL) were continuously stirred in a reservoir and circulated via a
peristaltic pump (Masterflex R© pump and speed controller, Cole-Parmer, Chicago, IL)
and tubing (Tygon R©, Saint-Gobain Performance Plastics Co., Akron, OH) through
the focus of the annular transducer, where a segment of dialysis tubing provided
acoustic access. The pump setting was chosen to achieve a slow average flow velocity
of 3.75 cm/s, which was calculated from a calibration of the volume flow rate of the
pump and cross-sectional area of the tube, in order to maximize opportunity for
ADV and for comparison to static experiments. Pulsatility of the flow was reduced
by including an in-line capacitor in the flow system. The solution, which was first
immersed and allowed to equilibrate to the 37◦C tank water, was changed between
each experiment. For each experiment, two pulses were transmitted one second apart
at a specific amplitude, and the next pair of pulses were fired after five seconds. This
cycle was repeated with increasing pressure amplitudes in both coarse (∼170 kPa)
and fine steps (∼40 kPa) to encompass a large range (0.22-4.43 MPa) and to refine
the threshold measurement in a small range (0.22-1.24 MPa), respectively. These
experiments were repeated five times. Thus, 10 measurements were taken at each
pressure in each of the two amplitude ranges, although 20 measurements existed for
pressures that were equivalent in the separate ranges.
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Only one detection method was used in these experiments. In flow, moving
scatterers would introduce additional noise into the RF signals that are detected
by the passive transducer, significantly reducing the signal to noise ratio (SNR).
Therefore, B-mode images were used to make threshold measurements.
To maintain a nominally homogenous distribution of CA and droplets and to
correctly characterize their behavior in concert, the majority of CA experiments were
performed in flow. These solutions were exposed to 20 ms tone bursts, although an
additional experiment of 105 microspheres/mL and droplet solutions were exposed to
20 µs pulses for a comparison of the effect on threshold due to short pulse duration
in the presence of CAs. An experiment where only droplets were exposed to 20 µs
tone bursts was also performed as mentioned in the previous section.
Although CAs are echogenic and provide substantial signal, scattering from
bubbles with larger cross-sectional area produced by ADV are distinguishable in
B-mode. The focus of the 10 MHz linear array was positioned on the proximal side of
the tube and the output power was maintained at a low setting, thereby (1) reducing
the signals from CA microbubbles while still detecting signal from ADV bubbles
and (2) reducing the possibility of destroying CA and/or affecting the threshold
measurement. Because the ADV threshold is low at a frequency of 10 MHz [7], the
linear array itself is also capable of vaporizing droplets.
2.2.6 Analysis of B-mode Images
B-mode images recorded during the pulse duration and CA studies were analyzed
for echoes from ADV bubbles, which appear as bright pixels in the image when
compared to the background. Detection for the presence of these echoes was
evaluated in terms of mean echo amplitude (MEA) in a given region of interest (ROI)
and is described in [5]. The ROIs, each consistent in size for a given study, were
positioned next to the focus of the annular array in the image and in the direction
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of movement of the bubbles produced by ADV. For the static pulse duration study,
the ROIs were positioned above the focus so that rising bubbles could be detected,
and for the CA study where the droplets and CA were flowing, the ROIs were
positioned downstream of the focus. The signal level at each pixel in the ROI was
then linearized assuming a simple log compression. The MEA, or the mean of the
decompressed pixel signal levels in an ROI, was then calculated and compared to
a baseline MEA value when no pulses were transmitted in order to detect a rise
in MEA and therefore the occurrence of ADV. Separate explanations of how this
analysis for the two studies was evaluated are described in further detail in the
Results section.
2.3 Results
2.3.1 Analysis for Pulse Duration Measurements
Detection with Imager
As described previously, the MEA for each B-mode image was computed. In this
pulse duration study, the MEAs for all images in a given cineloop were averaged.
A baseline mean MEA was then subtracted to compute the relative echo amplitude
(REA), which was then plotted as a function of peak Pr (Fig. 2.2). A large change
in REA indicates the ADV threshold. Therefore, the derivative of the REA vs.
Pr curve was taken to detect a change in slope. The point where the change in
slope exceeded a certain criterion was designated the threshold. This criterion was
established empirically from a small subset of the data and was subsequently applied
to all data. The ADV thresholds were then plotted in terms of pulse duration (Fig.
2.3).
Each data point found in Fig. 2.2 shows the result of consecutive pulses that
increase in amplitude; therefore, these plots reflect the REA as a function of both






























Figure 2.2: Example of REA against Pr for 500 µs pulses. The sharp change in slope
at approximately 5.5 MPa reflects a rise in REA due to bubbles created by ADV.
of the droplet concentration, Fig. 2.2 shows a decrease in droplet concentration as
a function of time, which is expected since DDFP droplets have a higher density
(C5F12, 1.6 kg/m
3) than water and would therefore settle to the bottom. However,
no correlation was found between any apparent variation in droplet concentration
and ADV threshold found in the data.
The placement of the ROIs vertically above the focus in the B-mode images
was important in order to detect rising bubbles. At near-threshold amplitudes,
long millisecond pulses created echogenic scatterers, which could be misinterpreted
as echogenic bubbles if they did not fall with gravity. Three frames in a B-mode
cineloop illustrating this process are shown in Fig. 2.4(a). One hypothesis is
that these sinking scatterers are DDFP droplet aggregates similar in concept to
aggregated forms of CAs during an acoustic pulse [11]. Further experiments would



























Figure 2.3: Threshold in Pr as detected in B-mode images. Error bars reflect the
standard error of the mean. (∗) Refers to 1000 pulses (20 µs each in duration) at a
PRF of 500 Hz. All other data points are the thresholds for single pulses with pulse
durations indicated along the abscissa.
referred to as sinking scatterers, only occurred during millisecond pulses. For
super-threshold amplitudes, ADV was confirmed with the persistence of bubbles
after insonification. Fig. 2.4(b) shows three frames after a super-threshold pulse was
transmitted. Echogenic scatterers seemed to disperse above and below the focus
due to radiation force (Frame 3), but scatterers in this case moved against gravity,
confirming the production of ADV bubbles (Frames 10 and 20).
Passive Detection
A 5 MHz single element transducer recorded the acoustic emissions and scattering
to detect IC. IC is defined as the growth and the subsequent collapse of a gas bubble
during an ultrasonic wave. Its acoustic emission is characterized by the appearance
of broadband noise. To specifically identify such an event, the Fourier transform was
computed for the entire RF waveform, and two frequency bands were analyzed by
33
the techniques described in [12], where the root-mean-square (RMS) was calculated
to quantify spectral content. These values were then plotted as a function of Pr.
To detect broadband noise, a frequency band between 2 and 2.4 MHz was chosen
because it lies between the fundamental frequency at 1.44 MHz and the second
harmonic at 2.88 MHz. A smaller more specific frequency band (between 0.7 and
0.74 MHz) was chosen to detect the subharmonic frequency at 0.72 MHz, which is
an indicator of the presence of bubbles. Bubbles in this case may be created either
by cavitation or ADV.
Two curves were then generated for each experiment. The RMS values for the
two frequency bands described above were plotted as a function of Pr. Fig. 2.5a is a
plot of the RMS values of the subharmonic range. Unlike the plots measuring REA
(Fig. 2.2), the plots for spectral content varied from experiment to experiment due to
variability in the number of inertial cavitation events that may occur with each tone
burst and also between the different pulse durations. Therefore, a criterion computed
from the baseline or pre-threshold RMS value was used for each separate experiment.
A histogram for each curve like that in Fig. 2.5b was used to determine the baseline
value. Since the increase in acoustic emission within a band is significant, a bimodal
distribution should exist. RMS values for a baseline value are then determined and
used as the criteria for ADV threshold as indicated by the dotted line (Fig. 2.5a)
and arrow (Fig. 2.5b).
Because of the statistical nature of IC, some events occurred at low amplitudes.
For example, a spike in RMS that met the criterion for ADV may have occurred but
did not recur with the following pulse at a higher amplitude. In order to choose a
threshold value that would reliably predict when IC would occur, these events were
not considered threshold. We required that at least two consecutive events occur to
be classified as threshold. Therefore, a median filter of size three was used (Eq. 2.1).
yi = median(xi, xi + 1, xi + 2), i = [1, N − 2] (2.1)
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Once the median value yi met the criteria, a threshold was determined. Fig. 2.6
shows the mean IC threshold for five measurements taken for each pulse duration.
Thresholds detected by both the presence of subharmonics and broadband noise are
shown.
Effects of Total “on-time” on Cavitation
To visualize the occurrence of IC and how it relates to pulse duration and on-time,
time-frequency plots were generated from the RF waveforms for both 20 ms pulses
and for 1000 pulses (20 µs each in duration). These two pulse sequences have
the same on-time, which is the cumulative duration of all tone bursts. Fig. 2.7a
shows three examples of scattering from 20 ms pulses at different amplitudes, and
Fig. 2.7b shows four examples from the series of 20 µs pulses also at different
amplitudes. Time-frequency plots for 20 ms pulses were generated by short time
Fourier transforms with the spectrogram function in Matlab (The Mathworks, Inc.,
Natick, MA) using 20 µs segments for comparison between the two pulse sequences.
RF waveforms in Fig. 2.7b were acquired in segmentation mode on the oscilloscope,
and each segment was time-gated to capture only the scattering during the short
transmitted pulse. Fourier transforms were then taken of each segment and also
displayed against time in Fig. 2.7b. Fig. 2.7c shows the results for 3.24, 4.20, and
4.85 MPa in Fig. 2.7b when the baseline spectrum (from the first time segment) is
subtracted from each of the spectra of the remaining pulses in the sequence.
2.3.2 Analysis for CA Studies
Similar to the analysis performed on the B-mode images in the pulse length
studies, ROIs were drawn in the images to detect a rise in pixel intensity and
therefore bubble production. In flow experiments, any bubbles created by ADV
would be quickly carried away after each pulse due to flow instead of buoyancy.
Therefore, an ROI positioned downstream of the focus was used to capture the
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transit of the ADV bubbles. Fig. 2.8 shows the MEA of such an ROI and how it
changes with time. The steady-state MEA can be seen during the first nine frames
and is then followed by two transient increases in MEA that characterize the passage
of bubbles and therefore successful ADV. Acoustic interference from the annular
transducer manifesting as white bands in the B-mode image is seen in frames 10, 11,
30, and 31, and the corresponding MEAs are therefore omitted from the MEA vs.
time plots.
From these plots, a threshold can be determined. Since the occurrence of each
of the two pulses is known beforehand, time intervals for a baseline MEA (first
nine frames), first pulse (frames 12-15), and second pulse (frames 32-35) can be
defined. Thus, MEA of the first and second pulses can be compared and evaluated
for successful ADV according to a threshold criterion computed from the statistics of
the baseline. Calculation of the criterion for ADV threshold is described as follows.
An accurate depiction of the baseline MEA was first obtained. Bubbles
unassociated with ADV occasionally traveled through the acoustic window, were
recorded in the B-mode cineloops, and were represented as aberrant spikes in the
MEA vs. time plots. These bubbles appeared to be vapor bubbles that formed in
tubing located beyond the acoustic beam. By comparing only the frames that were
expected to reflect either the first pulse (frames 12-15) or second pulse (frames 32-35)
to the baseline (frames 1-9), the probability that these spurious bubbles would affect
ADV detection was minimized. However, these bubbles can skew the data if they
appeared in the time frame used to calculate a baseline value. In order to accurately
represent the baseline value, an outlier detection method was used to identify spikes
in MEA in the baseline time interval and remove them from further calculations.
The box plot method, a standard method used for outlier detection, was applied
to the first nine MEA data points to detect an outlier. The points were first
rearranged in ascending order such that x1 < x2 < . . . x8 < x9. The interquartile
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range (IQR) was defined as Q0.75 − Q0.25, where Q0.25 = 1/2 · (x2 + x3) and
Q0.75 = 1/2 · (x7 + x8). An outlier was detected if it exceeded 1.5 · IQR above the
third quartile, Q0.75. Bubbles unassociated with ADV typically appeared as single
spikes (echogenic bubbles that raise the MEA), so the criterion was only applied for
the highest data point, or x9. Therefore, if x9 > 1.5 · IQR + Q0.75, then x9 was an
outlier and discarded from the baseline measurement. Outliers were detected 5% of
the time when using this method.
After any potential outliers were removed, the mean and standard deviation (SD)
were calculated for the baseline. An ADV event occurred if the MEA associated
with a pulse exceeded a criterion, which was computed from the mean and SD of
the MEA baseline values and which was assessed for reliability as follows. The
results (N=10 or 20 as explained in the Methods section) according to various
criteria, which differed only in the number of SDs above the mean, were compiled
and plotted as a probability for each Pr and for each CA concentration (10
3, 104, or
105 microspheres/mL) in Fig. 2.10a). To evaluate the reproducibility of the results,
we compared the results of an applied criterion with predictions based on a binary
logistic regression model (SPSS Ver.14, Chicago, IL) (Eq. 2.2). The predictors
in the binary logistic regression were based on exogenous factors including the




= m1 +m2 · I1 +m3 · I2 +m4 · p (2.2)
where m1, m2, m3, m4 are constants, I1 and I2 = 0 or 1 and are indicators for CA
concentration, and p is pressure. Though the agreement between the results using a
specified criterion was high (>90%) when the number of standard deviations varied
between three and eight, the best overall results were obtained with a criterion MEA
that exceeded the mean by five SDs (Fig. 2.9). The model is plotted alongside
the data in Fig. 2.10a using a five SD criterion and shows 50% probability of
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vaporization at 0.67, 0.51, and 0.41 MPa and 95% probability at 2.0, 1.92, and 1.8
MPa for CA concentrations of 103, 104, and 105 microspheres/mL, respectively. All
results are statistically significant (p<0.01). A control experiment that measured
the threshold in a solution with only 105 microspheres/mL of CA and no droplets
was evaluated according to the same five SD criterion and plotted with the previous
data (Fig. 2.10b). The threshold for the control experiment is substantially higher
than those for solutions containing both droplets and CA of any concentration,
suggesting that the thresholds measured here are in fact due to ADV and not the
CA themselves. Fig. 2.11a also further supports this argument in that a highly
echogenic signal appears only with the combination of droplets and CA, whereas
insonation at the same pressure amplitude actually decreases the signal level when
only CA are present (Fig. 2.11b). In addition, the thresholds measured when only
CAs are present may only reflect an increase in echogenicity due to CA aggregates
[11] that form in the side lobes of the acoustic beam (Fig. 2.11c).
2.3.3 ADV in Flow (Droplets Only)
A comparison was also made to observe any effects of flow on ADV. Fig. 2.12
shows the results of an experiment with only droplets in flow along with the ADV
threshold found in the static experiments for 20 µs pulses. Because of the possibility
of forming echogenic scatterers other than ADV bubbles during long 20 ms pulses, it
would be difficult to differentiate between the bright echoes due to bubbles and those
due to sinking scatterers in flow since both move in the direction of flow. Therefore,
20 µs pulses were used for this comparison. Fig. 2.12 shows that an average flow
velocity of 3.75 cm/s does not significantly affect ADV threshold for 20 µs pulses,
the shortest tone burst used in this paper. Because the annular transducer has a
6 dB lateral beam width of 1.14 mm and a single droplet will have moved 750 nm
in 3.75 cm/s flow, nominally all droplets in the beam will have been exposed to the
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entire 20 µs pulse. Thirty-four percent of the droplets in the 6 dB lateral beam width
will have been exposed to an entire 20 ms pulse, which may result in an elevated
threshold measurement due to limited detector sensitivity. Additionally, the results
for an ADV threshold experiment for 20 µs pulses in the presence of CA were plotted
in Fig. 2.12, illustrating a reduction in threshold for short pulses as well.
2.3.4 ADV in a Static Environment (Droplets and CA)
A limited number of experiments with CAs (105 microspheres/mL) and droplets
were performed in a static environment with 20 ms pulses since, as mentioned
previously, it is difficult to differentiate bubbles from sinking scatterers in a
flow environment. From these static experiments, we can confirm from B-mode
cineloops that at 0.43 MPa, echogenic scatterers rise after insonification. This is
the same pressure that generates echogenic scatterers in a flow experiment and is
approximately 20% that of the pressure required to generate sinking scatterers in
a static environment. The results from the static case support the claim that the
echogenic scatterers detected in the flow environment are in fact buoyant bubbles
produced by amplitudes as low as 0.43 MPa (MI=0.4).
Passive detection of acoustic scattering was also used in these limited static
experiments where droplets were mixed with CA at a concentration of 105
microspheres/mL. The apparent threshold for broadband noise in these experiments
was approximately 0.8 MPa, which is just above the range of the transition of
probability from 0 to 1 in the flow experiments. This difference may be due to the
inhomogenous distribution of CAs and droplets, which results from a difference
in buoyancy and consequently a separation of material. The elevated threshold is
not likely due to a difference in detector sensitivity since there is good agreement
between the thresholds detected by the imager and passive detector in the static
experiments (Figs. 2.3, 2.6). Nevertheless, these results indicate that IC is occurring
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at these low pressure amplitudes.
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Figure 2.4: (a) Sequential frames of a B-mode movie show effects of a 20 ms pulse at
1.86 MPa Pr . Frame 2 immediately follows the tone burst in Frame 1, during which
acoustic interference was seen and thus is not shown here. The tube was oriented
vertically, and the imager as well as the annular transducer was positioned to the left
of these images. Echogenic scatterers, nonbubbles, sink toward the bottom of the tube
as indicated by the circles in Frames 10 and 20. (b) Sequential frames of a B-mode
cineloop show effects of a 20 ms pulse at 3.74 MPa Pr . Frame 3 immediately follows
the tone burst, during which acoustic interference was seen. Acoustic interference
may span from one to two frames; in this case, interference spanned from Frame 1 to
2. Due to radiation force, the echogenic scatterers were pushed against the tube wall,
then dispersed above and below the beam. However, the scatterers in these images
rise toward the top against gravity, indicating the creation of bubbles, and therefore,
the occurrence of ADV.
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Figure 2.5: ADV threshold experiment for 10 ms tone bursts. (a) Example of the
spectral content of a subharmonic frequency band in terms of Vrms plotted against
Pr. A histogram of the Vrms values is seen in (b), in which the lowest Vrms values can
be separated (↓) as the baseline values. Vrms values greater than the baseline value





















































Figure 2.6: Threshold in Pr as detected by the passive 5 MHz passive transducer.
Error bars reflect the standard error of the mean. (∗) Refers to 1000 pulses (20 µs
each in duration) at a PRF of 500 Hz. (a) Shows threshold measurements based
on RMS values of the subharmonic range from 0.7-0.74 MHz. (b) Shows threshold
measurements based on the presence of broadband noise.
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Fig. 7. RF signals are displayed for single (a) 20 ms tone bursts and for (b) 1000 pulses (20 µs each in 
duration) at a PRF of 500Hz for various pressure amplitudes.  The associated time-frequency plots of the 
acoustic emissions are shown to the right in (a) and (b). (a) are examples of scattering at pressures 
above ADV threshold. (b) shows four examples of RF signals, where 3.24 and 4.20 MPa are considered 
below ADV threshold and 4.85 and 6.21 MPa are considered above threshold. (c) better illustrates the 




























































Figure 2.7: RF signals are displayed for single (a) 20 ms tone bursts and for (b) 1000
pulses (20 µs each in duration) at a PRF of 500 Hz for various pressure amplitudes.
The associated time-frequency plots of the acoustic emissions are shown to the right
in (a) and (b). (a) Examples of scattering at pressures bove ADV threshol . (b)
Four examples of RF signals, for which 3.24 and 4.20 MPa are considered below
ADV threshold and 4.85 and 6.21 MPa are considered above threshold. (c) Better
illustrates the change in time-frequency plots for waveforms in (b) when subtracting
the spectra of the scattering from the first 20 µs pulse. The time-frequency plot for
6.21 MPa is not shown in (c) because there is no clear baseline spectrum because IC
is occurring during the entire pulse sequence.
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Figure 2.8: Data points reflect the MEA of a given ROI through consecutive frames
in a B-mode cineloop. Statistics drawn from the mean MEA of the baseline, defined
here as the first nine data points, are used as criteria for ADV detection. Pulses
of the same amplitude are shown on the top and illustrate the timing of the pulse
firing during a given cineloop. Frames associated with acoustic interference with the












































Figure 2.9: Percentage of correct predictions made by a binary logistic regression
model for different criteria (number of SDs). Displayed on two different scales are
true negatives (no ADV) on the right ordinate and on the left ordinate, true positive
as well as an overall accuracy percentage (ADV, Overall). The maximum overall
percentage is 91.7% when using a criterion of five SDs above mean, meaning data





































































Figure 2.10: (a) Probability for ADV computed in the presence of 103 , 104 , and 105
microspheres/mL of Definity R© according to a criterion of five SD above mean. Data at
a given pressure amplitude show the result for N = 10 or 20 measurements. The entire
dataset, including results for Pr > 2 MPa, is not shown in order to better display the
transition of probability from 0 to 1. Curve fits are taken from the regression model
described in the text. (b) The entire dataset for the experiments in (a) is displayed
here along with data that were collected with only CA present (+), which show a
higher threshold than the solutions containing droplets. Data for (+) reflect N = 10
measurements.
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Figure 2.11: Frames immediately following acoustic interference are shown when
solutions containing both (a) droplets and CA and (b), (c) CA only are exposed to
20 ms pulses. ADV occurs in (a) at 1.24 MPa as indicated by the circle. At the
same pressure, CAs are destroyed as indicated by low echogenicity when droplets are
absent (b). Increasing the pressure to 5.46 MPa further causes high echoes in areas






















Figure 2.12: Probability results for ADV using 20 µs tone bursts. CA concentration
is 105 microspheres/mL. Circles and diamonds are data collected from ADV in flow
conditions. The white vertical line and the gray region indicate the mean ADV
threshold in Pr with no CA present and the associated standard error, respectively,
found in the static experiments using detection by B-mode cineloops.
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2.4 Discussion
The results show that the ADV threshold can be lowered by both lengthening
pulse duration as well as by adding CA. In evaluating these two methods in the
following sections, the occurrence and role of IC are also examined.
2.4.1 ADV Threshold with Droplets Only
From the static experiments, it appears that the ADV threshold remains relatively
constant (5.5-5.9 MPa) for pulse durations shorter than 1 ms for a 1.44 MHz carrier
frequency (Fig. 2.3). The threshold drops for pulse durations longer than 1 ms,
whereupon it appears to reach a plateau (3.8-4.6 MPa). Although 20 ms may
vaporize droplets at a lower Pr than microsecond pulse durations, it may not be
optimal for in vivo conditions because of heat deposition on overlying tissue layers.
Thus, we investigated if the total on time,” or the cumulative duration of all tone
bursts, had an effect on the ADV threshold by transmitting 1000 pulses at 20 µs
duration each (20 ms on time) at a PRF of 500 Hz (1% duty factor). Fig. 2.3
illustrates that the threshold for this case (mean of 4.25 MPa) is not statistically
significant from the threshold found for a 20 ms tone burst (mean of 3.96 MPa).
2.4.2 The Role of Inertial Cavitation in ADV
To investigate the role of inertial cavitation, where broadband noise signifies the
occurrence of an event, the acoustic scattering from the exposure of droplets to
ultrasound was recorded and compared to the data captured by the imager. The
thresholds as determined by the two different detection methods as well as the
threshold trends seen in terms of pulse duration (Figs. 2.3, 2.6) agree. A constant
threshold for pulse durations less than 1 ms is seen in Figs. 2.3 and 2.6 and is
consistent with the literature [13], where the time-averaged cavitation activity in
blood remained constant for pulse durations from 20 µs-1 ms at 1 MHz. Both curves
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also show that the threshold drops for pulse durations longer than 1 ms. There
is no indication in the data presented here nor in the literature that suggest that
the threshold would drop further for pulse durations longer than 20 ms [8]. This
consistency amongst the data suggests at least that IC plays a role in ADV at
frequencies below several MHz, though it is not clear whether the inertial cavitation
occurs inside or outside of the droplet in the experiments when only droplets are
exposed to ultrasound.
The elevated threshold for broadband noise of 4.5 MPa (MI=3.8) for 20 ms
pulses as compared to the results found in the literature [8] may be explained
when considering that IC and ADV are linked. With a lower f/number transducer
(1 versus an f/number of 2 in [8]), fewer higher harmonics accumulate because of
reduced time for high amplitude ultrasound propagation. Since high frequencies are
associated with a reduced ADV threshold, it may be more difficult for a low f/number
transducer to vaporize droplets. As this difference in threshold is shown in in vitro
experiments, transducer geometry and the effects of nonlinear propagation must
be further investigated for in vivo applications, where tissue provides substantial
attenuation. Although the nonlinearity coefficient β is similar for both water and
tissue (3.6 and 4-6.2, respectively [14]) the Goldberg number is much higher in water
than in tissue [15]. High harmonics generated during propagation through water
would be attenuated to some degree if instead the medium were tissue.
2.4.3 IC and “On-time”
The decrease in ADV threshold with increasing pulse duration along with the
comparable thresholds of equivalent on-time pulses is reminiscent of the behavior of
IC. It was shown that hemolysis, which reflects the quantity of IC, increased with
longer pulse duration and total “on-time” [9]. It may take as few as one available
nucleus to induce IC [9], and the opportunity for this to occur increases with longer
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pulse durations.
Examples of RF waveforms and the associated time-frequency plots are shown in
Fig. 2.7. Given adequate time for insonification, the chances of a cavitation nucleus
passing through the acoustic beam increases, and with increasing amplitude, the
initiation delay for cavitation decreases [16]. At 3.98 MPa, IC occurs only a portion
of the time during the 20 ms pulse (Fig. 2.7a). The duration of IC increases with
increasing amplitude and is eventually occuring during the entire pulse at (6.21
MPa). This increase in IC duration can also be seen in the multiple 20 µs pulses at
4.85 and 6.21 MPa (Fig. 2.7b). These amplitudes are considered above threshold,
where there is a spread in the spectral content indicating broadband noise. Fig. 2.7b
also shows RF waveforms at amplitudes below ADV threshold (3.24, 4.20 MPa) that
contain an interesting characteristic that is not seen in single 20 ms pulses. For the
case at 3.24 MPa, the scattering amplitude increases at approximately two thirds
into the duration of the pulse sequence and may appear to reflect the accumulation
of sinking scatterers, which was seen in B-mode cineloops. This is consistent with
an increase in scattering only at the fundamental frequency of 1.44 MHz. At 4.20
MPa, spikes in the scattering signal occur at two time points and appear to reflect
the generation of only a few bubbles per spike. Although there is a slight spread into
frequencies lower than the carrier frequency, it was not sufficient to meet threshold
criterion for subharmonics. The change in acoustic emissions during insonification
is better realized in Fig. 2.7c. Since the imaging array and passive single element
transducer could not be used concurrently, there is no direct evidence coupling the
aforementioned events though they can be seen during separate experiments at the
same amplitude.
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2.4.4 Inertial Cavitation External to a Droplet
The possibility that cavitation outside of the DDFP droplet may trigger ADV was
investigated by the addition of CA to the solution. CAs such as Albunex R© ([12],
[17][18][19]) and Levovist R© [18] have been shown to lower the IC threshold of the
host medium and in the case of Optison
TM
, lower it even further than the broadband
emission threshold for PFC droplets [8]. At diagnostic power levels, ultrasound
exposure of Definity R© has been shown to cause bioeffects thought to be associated
with cavitating microbubbles. These bioeffects include an increase in troponin T at
MI=1.2 [20] and petechial hemorrhages at an apparent threshold of 0.37 MPa for 1.7
MHz, or MI=0.3 [21]. These thresholds are significantly lower than the cavitation
threshold found with droplets present at MI=3.8 for 20 ms pulses. If cavitation is
linked to ADV as an initiator of the phenomenon, then there could be a reduction
in ADV threshold with the presence of CAs. We see that in Figs. 2.10 and 2.12,
there is indeed a reduction in threshold with the introduction of CA. In fact, it is
lowered by an order of magnitude for 20 ms pulses for the three CA concentrations
investigated here and by a factor of three for 20 µs pulses and 105 microspheres/mL
of CA. Although IC in the host medium may not always be the trigger for ADV,
these results indicate that it can be.
With a higher concentration of CA, there is a higher probability of cavitation
occurring with each pulse since there are more nuclei present [22]. As such, 105
microspheres/mL provide more nuclei and therefore there is a higher chance of IC,
and a higher chance that the event occurs in proximity to a droplet. The initial
threshold is considered here as the amplitude where there is at least one event
(Fig. 2.10a. Although this threshold is similar for all concentrations of CA, the
transition to achieving a probability of 1 rises more quickly with increasing Pr for
105 microspheres/mL. The logistic binary regression model showed that the results
of all three CA concentrations were statistically significant relative to each other
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(p<0.01), with the probability of an occurrence of an ADV event increasing with
the concentration of CA Fig. 2.10a. A similar result was seen with Levovist R© and
Albunex R© CAs, each of which had an IC threshold (detected by H2O2 production)
of 0.41 MPa independent of the concentration of CA added [18]. There was no
statistical difference in the amount of cavitation activity when comparing activity
increase from various dilutions of one or the other CA that were added to denucleated
phosphate buffered solution. However, when Albunex R© was added to a solution with
higher gas content, a notable rise in cavitation activity resulted. The solutions in the
experiments described in this paper were not degassed, and perhaps the combination
of higher gas content, droplets, and Definity R© provided substantially more nuclei to
show a significant difference between the three CA concentrations.
While the results of the CA studies in this section have been discussed in
comparison to thresholds of other types of CA, they do not reflect the effects of
all types of CA. It has been shown that CA oscillations differ with the type of
stabilizing shell [23][24], and we can reason from bubble dynamics that the type of
gas will also affect the contrast agent behavior. However, it has also been shown in
[21] that the bioeffects (petechial hemorrhages) resulting from IC occur at the same
pressure amplitude for Optison
TM
, Definity R©, and Imagent R©, and that the degree of
bioeffects depends on the number of microbubbles and is independent of the type
of CA. Since our passive detection method was used to identify the occurrence of
IC and the thresholds for IC and ADV were similar, the effect of CA on the ADV
threshold may be the same regardless of the type of CA.
2.4.5 ADV Threshold In Vivo
It is noted here that the findings of these studies may not represent droplet
behavior in blood. It has been shown in vitro that the ADV threshold increases when
blood is the host medium [5], although further investigation is required to determine
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the effects of blood flow in vivo. Additionally, the solutions in these experiments
were not degassed and were expected to be either at equilibrium with air as they
were circulated in the flow system, or slightly supersaturated in the static system,
where gas dissolved into the solution during refrigeration before being placed into
the 37◦C water bath. However, there did not appear to be a significant difference in
ADV threshold between the two systems (Fig. 2.12). However, human arterial blood
has a PN2 of 571 mmHg, PO2 of 102 mmHg and a PCO2 of 40 mmHg [25]. Arterial
blood, which is the target location for embolotherapy for cancer treatment, would
therefore have a slightly different gas content than that found in these experiments.
Still, with the addition of CA and consequently an even lower IC threshold, the
ADV threshold is likely to be also reduced in blood.
Additionally, for successful therapy in vivo, the bubbles resulting from ADV
must expand to an appropriate volume to be able to occlude arterial feeder vessels
to the cancer. While there has been success in a lepus kidney model [6] as mentioned
previously, verification of sufficient bubble sizes is necessary for applicability in
humans.
2.5 Conclusions
In order to achieve ADV at a low ultrasonic frequency and reduced input energy,
ADV threshold was measured as a function of pulse duration for single tone bursts
and for multiple pulses fired at a given PRF. By increasing pulse duration at 1.44
MHz, both the ADV and IC thresholds decreased in a similar trend. It was also
found that repetitive pulsing could induce the same effect at similar amplitudes as a
single pulse if the two have equivalent on-times. This may suggest a link between the
two phenomena, though proof of a causal relationship and determination of whether
IC occurs inside or outside of the droplet remains for future investigation.
In testing for the influence of IC on ADV, further experiments were conducted to
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evaluate the role of IC external to a droplet by the addition of CAs. The presence of
CAs greatly reduced the ADV threshold by an order of magnitude for 20 ms pulses
and by a factor of three for 20 µs pulses. Perhaps, with the use of CAs and by choice
of an appropriate pulse duration that reduces ADV threshold while minimizing input
power, routine ADV can be feasible at a range of useful locations in the body.
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CHAPTER III
Consideration of Attenuation and Efficiency in
Acoustic Droplet Vaporization for Embolotherapy
3.1 Introduction
The acoustic droplet vaporization (ADV) threshold is dependent on independent
variables such as frequency and pulse duration as discussed in the Chapter II. One of
the tradeoffs that arises from choosing a high versus low frequency, or short versus
long pulse duration is acoustic power. At high frequencies, less acoustic power is
required to achieve ADV [1] but considerably more may be needed when attenuation
is present. Smaller amplitudes are required to vaporize with long pulses than with
short pulses [2]; on the other hand, long pulse durations lead to increased time
average power and consequently increased risk of heating.
The addition of ultrasound contrast agent (CA) alleviates many of the decisions
that must be made to weigh these tradeoffs because the inertial collapse of CA
microbubbles appears to trigger the vaporization of a neighboring droplet [2]. For
lower frequencies, CAs have a low inertial cavitation (IC) threshold and can collapse
at pressures that are lower than thresholds for ADV. Thus, a significant reduction in
pressure amplitude is required to achieve ADV under these conditions if the inertial
collapse of CA is a trigger.
Having the ability to lower the ADV threshold with the addition of CA or
with lengthening pulse duration, we must now consider the effects of overlying
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tissue when attempting to vaporize droplets transcutaneously. Because the current
demonstrational target of embolotherapy by ADV is renal cell carcinoma (RCC),
we consider the acoustic access to the kidney. Three options are viable: through
the (1) abdomen, (2) intercostal space, or (3) retroperitoneum. The intercostal
space limits the effective aperture size of the transducer as sound will not easily
penetrate through bone; additionally, ultrasound (US) must first propagate through
the renal parenchyma, where acoustic shadowing by bubbles could effectively block
further distal ADV [3]. If the target is to vaporize droplets in the cortex, intercostal
penetration may be a reasonable option. Acoustic access through the abdomen or
retroperitoneum is more ideal for targeting the renal or a segmental artery; of these
two options, retroperitoneal access must penetrate through a larger portion of renal
parenchyma before reaching the arterial supply, and the position of the rib cage
and spine may confine positional adjustments necessary for anatomical variability.
Abdominal access also penetrates through some parenchyma and must contend with
the proximity of the bowel. Patient orientation and gravity can be used to reduce
possible interference from gas in the bowel.
Thus, in vivo studies will concentrate on acoustic access through the abdominal
wall, which is composed of layers of skin, fat, and muscle. On average, the human
abdominal wall as a whole has been found to be 2.4 ± 0.6 cm thick with a mean
attenuation of 1.13 dB MHz-1 cm-1 [4]. The set of experiments presented in this
chapter assess the success of ADV in an in vitro environment that simulates
abdominal transcutaneous ADV. In a simplified representation, overlying tissue
layers are simulated by using a 6 cm thick tissue-mimicking (TM) phantom
equivalent to 3 dB attenuation at 1 MHz, or approximately 3 cm human abdominal
wall. Under these conditions, ADV thresholds are measured with and without the
presence of CAs. The efficiency of the process is also measured with varying droplet
concentrations and pulse repetition frequencies (PRFs).
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3.2 Materials and Methods
3.2.1 Perfluorocarbon Droplets and Contrast Agents
Liquid perfluorocarbon droplets with albumin shells were manufactured according
to Kripfgans et al. [1]. Bovine albumin (A3803, Sigma-Aldrich, St. Louis, MO)
was first combined with saline at a concentration of 4 mg/mL. The albumin-saline
solution (750 µL) and dodecafluoropentane (250 µL) (09-6182, Strem Chemicals,
Inc., Newbury Port, MA) were then amalgamated (Wig-L-Bug, Crescent Dental
Mfg. Co., Lyons, IL) to form droplet emulsions. Immediately before performing
experiments, 1 mL stock droplet solution was diluted in 10 mL saline and filtered
with syringe filters (Whatman, Maidstone, UK) that were connected in series
and ordered in decreasing pore size (20, 16, 8, and 5 µm; Whatman, Maidstone,
UK). Based on previous measurements using a hemacytometer and imaged under
microscopy [5], a droplet concentration of 2.85 x 106 droplets/mL resulted from
this process and was designated as the standard concentration in this study. Other
concentrations, which are diluted after droplet filtration, are described in reference
to this standard value, such as a half, a quarter, and a tenth.
Definity R© (Bristol-Myers Squibb Medical Imaging, North Billerica, MA)
ultrasound CA, which consists of lipid shelled octafluoropropane gas microspheres,
was used in this study. Based on the appropriate dilution of the reported stock
concentration on the label, a concentration of 105 microspheres/mL in saline was used
for these experiments. Definity R© was activated 1-14 days prior to the experiment,
and gently agitated to a milky white color immediately before the experiments. PFC
gas replaced the headspace in the vial after CA was drawn from it. Four different
formulations were used in these experiments: droplets only, droplets and CA, CA
only, and saline only.
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3.2.2 Experimental Setup
The setup used in this study was similar to the flow environment setup described in
[2] and Chapter II. A 1 MHz annular array (10 cm aperture, 9 cm focus, 16 concentric
rings; Imasonic, Besançon, France) was focused in the center of a flow tube, where
a segment of thin-walled dialysis tubing provided acoustic access (5 mm diameter,
Spectra/Por R©, Spectrum Laboratories Inc., Laguna Hills, CA). All elements were
driven in phase for these experiments. Droplets and/or CA were continuously stirred
in a reservoir and circulated with a peristaltic pump (Masterflex R© pump and speed
controller, Cole-Parmer, Chicago, IL) through the flow tube and acoustic window,
where they were exposed to ultrasound. The maximum flow speeds were nominally 8
and 16 cm/s, and an in-line bubble trap served as a capacitor to ostensibly maintain
constant flow and remove large bubbles from circulation.
For simulation of overlying tissue, a tissue-mimicking (TM) phantom consisting
of two layers of 16 x 16 cm2 Zerdine R© slabs (1540 m/s sound speed, 0.5 dB MHz-1
cm-1 attenuation, CIRS, Inc., Norfolk, VA), one 2 cm thick and the other 4 cm thick,
was positioned between the annular array and the flow tube. A frame to hold the
phantom was put in place prior to any measurements for simple insertion of the
Zerdine R© slabs between measurements. Because Zerdine R© is hydrophilic and any
uptake of water would alter its acoustic properties, the slabs were contained in a
re-sealable plastic bag with castor oil (CA208, Spectrum Chemical Manufacturing
Corp., Gardena, CA) (c = 1.477 mm/µs, ρ = 0.969 g/cm3 (Onda Corp., Sunnyvale,
CA)) for coupling. Excess air was suctioned from the bag. As will be described later,
the total insertion loss was measured. The entire setup was situated in degassed
and deionized water that was heated and maintained at approximately 37◦C (Ex 7,
ThermoNESLAB, Newington, NH).
A 5 MHz phased array (FPA 5 MHz, System Five, General Electric Vingmed,
Milwaukee, WI) inserted into the center hole of the annular array was used to
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align the focus of the annular array with the target. For alignment purposes, high
amplitude pulses were transmitted from the annular array to induce IC in degassed
deionized water and consequently bubble clouds at the focus. These clouds were
visible in the B-mode images from the 5 MHz phased array, and their location was
noted for alignment with the flow tube.
The ADV threshold was determined by transmitting successive US exposures with
increasing applied pressure amplitudes in a step-wise fashion, starting at ambient
pressure and ending at pressures beyond the ADV threshold. Each US exposure
at each pressure amplitude consisted of 10-cycle pulses that were transmitted at a
specified pulse repetition frequency (PRF) for approximately five seconds. A 10 MHz
linear array (FLA 10 MHz, System Five, General Electric Vingmed, Milwaukee, WI)
was positioned 90◦ from the annular array and on the distal side of the TM phantom
to image any bubbles resulting from ADV. The 10 MHz linear array was used for
ADV detection rather than the 5 MHz phased array for two reasons: (1) it provided
superior images and (2) its placement allowed imaging to remain uncompromised by
additional attenuation introduced by the TM phantom. However, because the 10
MHz imager itself is capable of vaporizing droplets, the power output of the imager
was minimized by setting the mechanical index (MI) to 0.3. The B-mode images
were then transferred via video output to a desktop computer, where frame grabbing
software (NIH Image Version 1.61, U.S. National Institutes of Health, Bethesda,
MD) captured the images at a 20 Hz frame rate and recorded them in TIFF format.
This image transfer was ideal for efficient data storage due to the larger memory
capacity of the desktop computer. The B-mode TIFF movies were then analyzed to
determine the ADV threshold.
Table 3.1 summarizes the acoustic parameters for each formulation tested. For
formulations containing CA, a slower flow rate was used for better detection of
the resulting bubbles and because it has been shown to be successful in the past
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Table 3.1: Summary of Experimental Parameters
Agents Attenuation Velocity [cm/s] PRF [Hz] N
Droplets no 8 100 5
10-500 1
500 4
yes 16 100 5
Droplets + CA no 8 10 7
yes 8 10 7
16 20 5
CA only yes 16 20 5
8 10 5
Saline only no 16 20 1
yes 16 20 1
Threshold experiments were conducted for the acoustic parameters for the specified agent(s) listed,
where velocity refers to flow velocity, PRF refers to pulse repetition frequency, and N refers to
the number of repetitions. Two Zerdine R© slabs totaling 6 cm in thickness were used to provide
attenuation.
for measuring ADV thresholds; however, in order to make a comparison to the
formulations containing only droplets, the flow velocity also was matched at 16 cm/s
and the PRF was increased proportionally. The implications of the range of PRFs
used is discussed subsequently in the Results and Discussion sections. Although the
presented results were attained using the 10 MHz linear array, a limited number
of experiments were performed using the 5 MHz phased array to detect bubbles
produced by ADV from a different imaging plane.
3.2.3 Transducer Calibration
The 1 MHz annular array was calibrated with an in-house fiber optic probe
hydrophone (FOPH) [6] in de-ionized and 80% degassed water. The output pressures
resulting from a 10-cycle excitation pulse and a range of applied voltages were
measured at the spatial maximum. After a free water calibration, where the spatial
maximum was located and named Position 1, the setup for in vitro experiments was
reproduced by inserting the Zerdine R© slabs immersed in castor oil, along with its
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holder between the annular array and the hydrophone. The derated pressures were
measured again at Position 1 with the attenuating layers in place. With greater
nonlinear absorption, the location of the spatial maximum in fact changes with
the presence of the TM phantom. The shifted spatial maximum was then located
(Position 2), and the resulting pressures were measured again for a range of applied
voltages. During in vitro experiments, the flow tube was always aligned with the
spatial maximum in the acoustic field.
A theoretical fit derived from the Khokhlov-Zabolotskaya-Kuznetsov (KZK)
equations was used to characterize the transducer response in peak rarefactional
pressure (Pr) to the range of applied voltages. The true attenuation provided by the
TM phantom was also characterized since the addition of the castor oil, re-sealable
plastic bag, and discontinuity between the slabs are causes of additional absorption
and/or scattering. These results are provided below.
3.2.4 Image Analysis
The TIFF images recorded by the frame grabber were converted to the appropriate
linear grayscale before threshold analysis. Because the grayscale of the images saved
in TIFF format was different from that used by the System Five diagnostic scanner
(echoPAC format), the appropriate conversion was needed to recover the original
image which is quantified in terms of the relative echo amplitude.
A calibration was performed in order to determine the correct grayscale conversion
from TIFF to echoPAC format. Several images of the same Zerdine R© slabs used
in the experiments were captured and saved in both echoPAC and TIFF format.
Gain, time gain compensation, and focal depth were varied for each image. The
combination of attenuating medium and variation in imaging parameters allowed
for testing of the full dynamic range and any change in conversion with imaging
parameters. The echoPAC pixel intensities were extracted using proprietary software
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(General Electric, Milwaukee, WI) operating in Matlab (The MathWorks, Inc.,
Natick, MA) and were then decompressed according to the algorithm provided by
the manufacturer. The pixel values between the TIFF images and the decompressed
echoPAC images were compared and a quadratic function was fit to the conversion
curve. This grayscale conversion was applied to all images.
3.3 Results
3.3.1 Sound Field through Zerdine R©
Fig. 3.1a shows results of four acoustic field calibrations performed in degassed
deionized water and measured with an FOPH. A theoretical curve for achievable
Pr was generated using time-domain methods to solve the KZK equation [7], where
the annular array was modeled as a single element transducer. Attainable pressures
were simulated from a range of source pressures, and assuming a linear relationship
between source pressures and applied voltages, a fit was produced.
The attenuation effects from the TM phantom can be seen in Fig. 3.1b, where
the derated pressures (Position 2) as measured by the FOPH is plotted as a
function of the expected pressure in a water path. Otherwise stated, for an applied
voltage, the maximum pressure attained in a water path and the maximum pressure
attained through the TM phantom is shown. The slope of the fit in Fig. 3.1b is
0.7 and corresponds to -3.1 dB in pressure, indicating that there was no significant
contribution from the layer of castor oil, bag, or gap between Zerdine R© layers.
Additionally, a calibration confirmed that the same pressures were achieved with
and without the phantom holder.
With the insertion of Zerdine R©, there is a slight shift in the spatial maximum in
the proximal direction by approximately 1.5 mm (Fig. 3.2). In order to understand
the effects of the TM phantom, the spectral composition of two waveforms with the
same Pr, one traveling through water and one traveling through the phantom, were
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Figure 3.1: a) Data from four different free water calibrations, where pressure was
measured with a fiber optic probe hydrophone. The data was fit with a simulated
curve derived from the KZK equation. b) For a given pressure attained in a water
path, the corresponding in situ pressure from the same acoustic source achieved
through an attenuating gel is plotted.
examined. The Fourier transforms of the waveforms are compared in Fig. 3.3, where
it appears that the amplitudes at the fundamental frequency and harmonics are
nominally equivalent with the exception of the third harmonic at 3 MHz.
3.3.2 Threshold Analysis
After grayscale conversion and decompression, the B-mode images captured by
the 10 MHz linear array were analyzed to detect the creation of bubbles according to
procedures described in [1] and Chapter II. A region of interest (ROI) in the B-mode
images was chosen downstream of the focus to capture persisting bubbles. The mean
echo amplitude (MEA) was then computed by averaging the pixel values within the
ROI for each frame, and subsequently over all 100 frames in a given movie. This
calculation was performed for each movie, where each movie captured US exposures






















Figure 3.2: Axial beam profile with Zerdine R© insertion. Each data point indicates the
Pr at each location normalized to the maximum value of the second degree polynomial
fit (line). Position 1, or the spatial maximum in a water path, is located at 0 mm.
When the majority of the water path was replaced with an attenuating medium, the
spatial maximum shifted approximately 1.5 mm (Position 2) toward the transducer.
The amplitude at Position 2 was only 2% greater than that at Position 1 when the two
locations were measured in the presence of Zerdine R©. This ratio, however, increases
with amplitude.
in a given experiment. The baseline MEA, i.e. the MEA during no US exposure,
was subtracted from all MEAs within an experiment to obtain the relative echo
amplitude (REA).
The pressure amplitudes along with their associated REAs were then plotted
and analyzed to detect the ADV threshold. Fig. 3.4 shows examples of REA vs. Pr
curves for droplets only and for droplets with CA. When only droplets were present,
a sharp rise in REA indicated the ADV threshold and was preceded by a slight linear
decrease in the sub-threshold REA, the reasons for which will be discussed shortly.
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Figure 3.3: The Fourier transforms of two waveforms with an in situ Pr of 5.4 MPa.
One waveform was measured in a water path, and the other through a Zerdine R© TM
phantom.
Thus, the curve could be defined by two line segments (Eq. 3.1) [1],
REA(p) = (a1 · (p− ptheshold + b) · w1 + (a2 · (p− ptheshold + b) · w2 (3.1)
where p is Pr, and an and wn are the slopes and windowing functions for each line
segment, respectively. An example of an REA vs. Pr curve with its associated curve
fit is shown in Fig. 3.4a. This threshold detection technique was also applied to
curves associated with experiments with only saline. In this case, a rise in REA was
due to bubbles generated by IC.
With the presence of CAs, the REA vs. Pr curve takes a different shape. Contrast
disruption occurs at low amplitudes in comparison to ADV, manifesting as a loss in
echogenicity. The loss also results in a decrease in REA, which is illustrated in Fig.
3.4b. Although the REA also decreases when only droplets are present (Fig. 3.4a),
the decrease appears linear and unlike the rapidly diminishing curve for droplets and
































Figure 3.4: REA vs. Pr curve for formulations of (a) droplets, where the associated
curve fit is also plotted, (100 Hz PRF) and (b) droplets with CA (10 Hz PRF). Both
experiments were conducted in the absence of a TM phantom.
the solution is circulated.
Fig. 3.5 plots a normalized REA, REA/|REAmin|, to compare the functional
dependence between the case of droplets with CA and CA only. With different
imaging parameters such as gain, focal depth, and experimental variation in dilution,
the absolute loss in REA may change from experiment to experiment. The point
at which the two REA/|REAmin| curves deviate suggests new bubble production.
Because REA/|REAmin| for only CA exponentially decays and does not rise with
increasing pressures within the range of Pr tested, the possibility that the bubble
production is due to coalesced or aggregated CA, or even from IC, can be excluded.
This rise in REA/|REAmin| is most likely due to ADV.
Therefore, the ADV threshold in the presence of CAs was determined as the Pr
at which the REA/|REAmin| began to deviate from the REA/|REAmin| curve for
only CA. This point was consistently the point at which REA/|REAmin| began to
increase. In order to find the shift from negative to positive slope, a second degree

























Figure 3.5: Example of REA/|REAmin| vs Pr curve for when droplets are mixed with
CA and for CA only. Both experiments were conducted in the presence of a TM
phantom. As such, Pr values are in situ.
signified the ADV threshold.
The threshold results in terms of in situ pressures and applied voltage to the
transducer are summarized in Fig. 3.6. Using a t test for unequal variances, the
difference when comparing the results for ADV with and without attenuation when
only droplets were present were statistically significant (p<0.01). The thresholds for
formulations with CA were much lower (p<0.001) such that approximately the same
amount of source power was necessary to achieve ADV through an attenuating tissue
mimicking (TM) phantom as it was without attenuation and with only droplets. The
threshold when droplets and CA were circulated at a flow velocity at 8 cm/s was
slightly reduced when the TM phantom was inserted (p<0.04). With a flow velocity
of 16 cm/s and with attenuation, the threshold when compared to the slower velocity
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at 8 cm/s with attenuation was different (p<.01) but was statistically the same as
the 8 cm/s case without the TM phantom.
(a) (b)
Figure 3.6: Summary of threshold results. Results in terms of in situ Pr and voltage
applied to the transducer are in (a) and (b), respectively. The IC threshold was
measured with only saline, and in all other measurements, the ADV threshold was
measured. For the cases when there were droplets and CA (D+CA) or only saline,
the PRF was 20 Hz for a 16 cm/s flow rate; when only droplets were present, the PRF
was 100 Hz. For an 8 cm/s flow rate, a 10 Hz PRF was used. Error bars indicate
standard deviation.
In order to confirm that the presence of the phantom holder did not affect the
measurements, a limited number of experiments with only droplets were conducted
without the phantom holder. The thresholds measured under these conditions were
not statistically different from the thresholds measured with the phantom holder.
3.3.3 Image Analysis for Efficiency
ADV efficiency was explored with varying PRFs and droplet concentrations. In
order to evaluate efficiency, B-mode movies were compared within a given setup,
where equivalent imaging planes were captured. Small variations in alignment,
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although insufficient to affect the detection of the ADV threshold, can capture
different parts of the parabolic flow profile within the tube and may affect an
accurate comparison of droplet conversion. Therefore, B-mode movies from different
setups were not used in the same analysis. Four lines of pixels (similar to four partial
M-mode lines) positioned in the flow tube were taken from each image, namely
upstream of the focus and at the focus, as well as two cross-sections downstream of
the focus (Fig. 3.7). The decompressed pixel intensities were integrated across these
lines and were then averaged over the 100 frames in the movie. The integrated lines
upstream of the focus, at the focus, just downstream of the focus (“Downstream”),
and further downstream of the focus (“Downstream 2”) will henceforth be referred
to as IMup, IMf, IMd1, and IMd2, respectively. IMf, IMd1, and IMd2 were normalized
to IMup in order to compute an efficiency factor associated with each of the three
positions. Any differences in IMx for different depths due to focusing effects of the
imager were corrected by simple multiplication based on baseline measurements
taken without the application of the ADV field. Here, efficiency factor is only a
relative metric, and does not describe the efficiency of droplet conversion in terms of
an absolute value. Previous measurements have shown that at a higher frequency
of 4 MHz, approximately 26% of droplets are converted to gas bubbles with each
pulse [8]. It has not yet been determined whether this conversion efficiency holds for
different frequencies.
The efficiency factor is plotted in Fig. 3.8 for 100 and 500 Hz PRFs and different
droplet concentrations. The efficiency factor for both PRFs remains relatively
constant for the two downstream values, but at the focus, the efficiency factor
(IMf/IMup) decreases with increasing concentration. IMf, however, is the same
regardless of the droplet concentration; generally speaking, absent of any ADV, IMx
increases with increasing droplet concentration. Consequently, the ratio between IMf
and IMup decreases with increasing droplet concentration.
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Figure 3.7: a) Lines of pixels taken upstream of the focus, at the focus, and two
downstream of the focus are used to evaluate efficiency of ADV. This single frame is
taken from a B-mode movie capturing events during an US exposure with 5.4 MPa
Pr and 100 Hz PRF. b) The pixel values in these lines are displayed. The lines
positioned at the focus and downstream of the focus show elevated pixel intensities
when compared to the upstream baseline position.
When comparing PRFs, the efficiency factor is 2-3 times greater at 100 Hz than
at 500 Hz. Upon closer examination of the role of PRF (Fig. 3.9), we find that a
monotonic relationship does not exist between PRF and efficiency factor; instead, an
optimal PRF is apparent.
Fig. 3.10 shows the calculated efficiency factor for US exposures of different
amplitudes in an experiment. These data were collected when droplets were mixed
with CAs. Unlike the cases in Fig. 3.8 and in the data collected for high PRFs
(>100 Hz) in Fig. 3.9 where the efficiency factor at the focus was generally higher
than that calculated for either downstream value, the efficiency factors for both
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Figure 3.8: The pixels in each cross-sectional line were integrated and normalized to
the baseline, i.e. the integrated value of the line placed upstream of the focus, to
compute the efficiency factor. Thus, the efficiency factor is the multiplicative factor
of the baseline droplet echogenicity. The efficiency factors for the focus, downstream,
and downstream 2 positions are plotted against relative droplet concentration where
a value of 1 indicates a concentration of 2.85 x 106 droplets/mL. A flow speed of
16 cm/s and an amplitude ∼40% higher (5.4 MPa Pr) than the ADV threshold was
used for the measurements shown here. Data points represent single experiments in
a given setup where the same imaging plane was used.
This inversion could logically be attributed to the difference of an order of magnitude
in PRF as droplets and droplets with CA received pulses at PRFs of 100 Hz and
10 Hz, respectively. However, Fig. 3.11 compares sequential IMx values in a movie
for a formulation of droplets and CA (Fig. 3.11a) and droplets only (Fig. 3.11b).
Unlike the majority of CA and droplet experiments, the same PRF of 100 Hz was
used for these two experiments. The pressure amplitude in these examples for the
case of droplets and CA was 200% greater than the measured ADV threshold for



























Figure 3.9: A comparison of the efficiency factor for varying PRFs for US exposures
at 5.4 MPa Pr. The same calculated droplet concentration of 2.85 x 10
6 droplets/mL
were used for these measurements. No CA were added.
greater than the measured ADV threshold for only droplets. Even at an amplitude
significantly greater than the ADV threshold, IMf,d1,d2 is more sporadic with CA and
does not exhibit a clear separation from IMup (Fig. 3.11a). Reducing the PRF to 10
Hz (Fig. 3.11c) shows a more apparent separation of IMup and was therefore used
for the majority of experiments involving CA. Nevertheless, the distinct behavior of
IMf,d1,d2 seems to suggest a different ADV mechanism when CAs trigger the process.
A prevailing trend seen in Figs. 3.8 - 3.10 is that the for the “Downstream
2” M-mode line is greater than or equal to the “Downstream” M-mode line.
This increase could be caused by bubble growth, which will cause an increase
in echogenicity. The vaporized droplets have traveled a longer distance to reach
“Downstream 2” and therefore have had more time to take on gas. For a mean flow
rate of 8 cm/s (16 cm/s maximum flow rate), droplets will take approximately 100
ms on average to reach the “Downstream 2” M-mode line, which is more than double


























Figure 3.10: The efficiency factor for a range of amplitudes is plotted for US exposure
of a combination of droplets and CAs of the same concentration.
diffuse into the bubble at 100 ns while others begin to diffuse at 1 ms, allowing the
bubble to exponentially reach its maximum size at 2 s. The bubbles would double
their size in 100 ms.
It was considered that radiation force may have played a role in the different
efficiency factors at high PRFs. The data evaluated for droplet conversion were all
collected with the 10 MHz linear array that was oriented perpendicularly to the
direction of propagation of the annular array, and any droplets/bubbles that were
created could have been pushed beyond the imaging plane. Thus, a limited number
of experiments were performed with the 5 MHz phased array that was situated in the
center hole of the annular array. If bubbles experienced radiation force, they would
still be detected by the 5 MHz imager. However, the data collected with the 5 MHz
imager, which captured the axial plane of the annular array, produced similar results
as the 10 MHz imager, which captured the lateral plane. It is therefore unlikely
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Figure 3.11: IM for sequential frames in a B-mode movie for (a) droplet and CA and
(b) droplets only. PRF for both US exposures was 100 Hz. (c) shows IM values for
a solution of droplets with CA for US exposures of 10 Hz PRF.




The threshold experiments that were summarized in Fig. 3.6 show that droplets
were reliably vaporized through a TM phantom with 3 dB of attenuation and
that ADV is highly dependent on the value of Pr for all formulations. Although
the threshold measurements for only droplets with and without attenuation were
statistically different, the mean values differed by only 11%. Since the rarefactional
half-cycle is dominated by low frequencies, the fundamental frequency appears to
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have a large effect on ADV rather than the higher harmonics, although the harmonic
content was not substantially altered by the presence of the attenuating material as
evidenced by Fig. 3.3.
For the solutions containing CA and droplets, there is inconsistency within the
data. When comparing thresholds for the 8 cm/s flow velocity, the same trend as
seen with only droplets might be expected. However, the inverse relationship exists
as the threshold decreases with the addition of the TM phantom. Increasing the flow
velocity to 16 cm/s increases the threshold, which is expected since faster flowing
bubbles are more difficult to detect. Still, this threshold is not statistically different
than that for droplets and CA at 8 cm/s flow velocity. This inconsistency seems to
suggest variability in the interaction of droplets and CA due to perhaps dilution or
a focus whose level of aberration changes from experiment to experiment with the
propagation path through the TM phantom.
The addition of CA reduced the ADV threshold such that approximately the
same amount of input power was required when droplets were vaporized with
CA and attenuation, as when droplets were vaporized without CA and without
attenuation (Fig. 3.6b). CA lowered the ADV threshold by 1.5-2 times, which is
also similar to the results found for repetitive short microsecond pulses at 1.44 MHz
in [2]. As discussed in [2] and in Chapter II, the lowered ADV threshold with CAs
present indicates that IC external to the droplet may be an initiator for ADV. It
appears from Fig. 3.5 that there may be one of two effects that must occur before
a vaporization event occurs. First, the fall in REA/|REAmin| may be initially due
to the disappearance of CA unassociated with IC, but upon reaching threshold, the
CAs inertially collapse and trigger the surrounding droplets. Secondly, a certain
amount of IC may be required before ADV can be triggered. The diminishing CA
levels may be due to contrast disruption. However, ADV does not occur until higher
pressures are reached, perhaps due to the increased amount of IC that occurs within
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the widening contrast disruption zone or that the strength of the IC collapses are
sufficient. In any case, once a requisite amount of IC occurs, ADV thresholds do not
change significantly, which was witnessed when an increase in CA concentration did
not substantially lower the ADV threshold [2].
It is also possible that IC is the initiator when CA are absent. In this case, the
threshold for ADV absent of any CA is half that of IC in saline indicating that the
droplets, in providing inhomogeneities in the liquid, could lower the IC threshold
in the host fluid. However, it has been shown through high speed photography
that cavitation can occur inside the droplet itself [9]. These two mechanisms may
be dominant in their own frequency domain as with higher frequencies (or larger
droplets), the droplet may interact more with the ultrasound wave.
3.4.2 Efficiency
The efficiency of droplet conversion for a solution of droplets and CA was difficult
to quantitatively assess in comparison to results from a solution with only droplets.
As discussed in the previous section, the effective disruption zone for CA is larger
than the effective vaporization zone for ADV once the ADV threshold is reached.
The PRFs used for droplet and CA experiments were therefore lowered by an order
of magnitude in order to ensure that the intended population of CA and droplets
was replenished for each US pulse. However, a maximum flow rate of 16 cm/s and
a 20 Hz PRF seems to be the apparent optimal PRF even when only droplets are
present. It may be that, with the flow parameters and center frequency used in
these experiments, a slow PRF of 20 Hz (Fig. 3.9) will allow optimal efficiency with
minimal power input into the system. However, further investigation is required
to compare droplet conversion efficiency with and without the presence of CAs.
The amount of bubbles following an US pulse must be measured and differentiated
from the remaining droplet and CA population. Optical measurements in a static
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environment would allow for single bubble detection for counting, as well as the
ability to differentiate between converted droplets and the remaining agents.
When considering that IM is a direct indication of echogenicity, it has been seen
that the echogenicity at the focus remains the same when the PRF was high (100,
500 Hz) regardless of droplet concentration (Fig. 3.8). It may be inferred that the
same amount of bubbles were generated in the focal region, be it from IC or ADV.
However, if pulsing was too frequent, the bubbles that were created at the focus may
have been destroyed before leaving the field. With a PRF of 100 Hz, a maximum
flow rate of 16 cm/s assuming a parabolic flow profile, and full width half maximum
(FWHM) of ∼1.5 mm, each droplet that passed through the field was exposed to
at most one US pulse. For average flow, each droplet was exposed to two pulses. A
decrease in the efficiency factor is observed if the exposure is increased to 4 pulses per
droplet on average. In fact, as mentioned previously, for a 1 MHz carrier frequency,
a 20 Hz PRF is more efficient at converting droplets to gas bubbles than higher or
lower PRFs (Fig. 3.9).
A simple equation can be used to calculate the optimal PRF for any flow rate
and beam width. Assuming that 20 Hz is the optimal PRF, or PRFopt, based on the
data points in Fig. 3.9, the ratio between the average transit time for the FWHM
beam width ((beamwidth)/(flowrate) =18.7 ms) and the pulse repetition period
(PRP) (50 ms) is 0.375 for the parameters used in these experiments. Thus, given





It is noted here that this change in efficiency appears not to be applicable to other
frequencies most likely because the threshold for IC increases for higher frequencies
and with bubble size [10]. At 4 MHz, data has shown that efficiency increases with
PRF as each sequential pulse continues to vaporize a percentage of the remaining
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un-vaporized droplets [8]. The efficiency saturates at high PRFs as the remaining
droplet population diminishes but does not decrease as in the case with a 1 MHz
carrier frequency.
From literature [10][11][12][13], pressure thresholds for inertial collapse can be
theoretically predicted. Based on the perfect gas law and an assumed adiabatic
collapse, attained temperatures can be related to bubble size (Eq. 3.3)






where γ is the ratio of specific heats, T0 is the initial temperature, T
′ is the maximum
temperature, R0 is the initial bubble radius, and R
′ is the minimum bubble radius.
The analytical theory in [12] improves upon that presented in [11], which applies
to bubble sizes greater than 10 µm for frequencies below 2.5 MHz. Apfel [12] includes
the consideration of surface tension and viscosity, expanding the relevance of the
model to bubble sizes greater than 0.5 µm in radius and to frequencies representative
of biomedical applications. Holland and Apfel [13] further examined the effects of
surface tension to be able to consider bubbles as small as 0.1 µm in radius. Since the




























where f is the insonating frequency, ρ is density, P0 is the ambient pressure, p is
the peak acoustic pressure amplitude normalized to ambient pressure, and pb is the
Blake threshold normalized to ambient pressure.
The theoretical thresholds were computed (Mathematica, Wolfram Research,
Inc., Champaign, IL) for various bubble sizes and frequencies (Fig. 3.12) for an
initial temperature (T0) of 310 K, or 37
◦C, and attained temperatures (T ′) of 2500
K. The ADV threshold at 1 MHz is slightly higher than the threshold for inertial
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Figure 3.12: a) Collected data for ADV thresholds and theoretical predictions [12]
for inertial collapse for bubbles 10, 20, and 60 µm in diameter. (•) are collected data
from [14], (4) are from previous publications for microsecond repetitive pulses [3][2].
b) Theoretical predictions for inertial collapse for bubbles of a range of diameters for
insonation at 1 MHz. Bubbles resulting from ADV span the range of 10-60 µm in
diameter [14].
bubble collapse at 3 MPa for a bubble with a 60 µm diameter (Fig. 3.12a), the
largest bubble size measured from ADV of filtered droplets [14]. Bubbles can be as
small as 10 µm, where the threshold for inertial collapse is approximately 0.6 MPa
and is lower than the measured ADV threshold (Fig. 3.12b).
It therefore appears advantageous to choose the lowest possible frequency that,
for the bubble size distribution created by ADV, has a higher threshold for inertial
collapse than it does for ADV. This frequency would be the optimal frequency for
tissue penetration while retaining high conversion efficiency. For a 1 MHz insonating
frequency, the threshold for inertial collapse increases by almost a factor of three for
bubbles ranging from 10-60 µm. It appears that in Fig. 3.12a, bubbles created by
ADV may only be safe from inertial collapse upon the arrival of the second US pulse if
the frequency is above 4 MHz and the applied pressure is just above ADV threshold.
However, 10 µm bubbles only comprise a small percentage of the total number of
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bubbles and perhaps are not worth the sacrifice in frequency. The population of 20
µm bubbles is the largest [14], and perhaps should dictate the optimal frequency.
Further investigation is needed to ascertain the most advantageous balance between
droplet conversion efficiency, insonating frequency, and ADV pressure threshold.
3.5 Conclusion
Transcutaneous ADV was simulated in vitro in the experiments presented in this
study. It was found that ADV was reliably achieved through 6 cm of attenuation,
and that, with the annular array used, there is sufficient power capacity to overcome
the effects of even more attenuation. The option to reduce the power input while
retaining the ability to vaporize droplets is available with the use of CAs. However,
with CAs, PRF must be reduced in order to ensure that a fresh supply of CAs
accompany a fresh supply of droplets. PRF also becomes important at these low
frequencies where the bubbles created from droplets are subject to inertial collapse if
they remain in the acoustic field. At 1 MHz, PRF must be reduced in order to avoid
subsequent bubble destruction. Thus, for the different conditions under which ADV
may be optimal, there are considerations that must be understood.
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CHAPTER IV
Spatial Control of Gas Bubbles and their Effects
on Acoustic Fields
4.1 Introduction
Insonified microbubbles can serve as various tools for tissue treatment. They
play beneficial roles in creating lesions by both cavitation and the enhancement
of thermal ablation, though the mechanisms for these two classes of therapeutic
regimes are distinct.
In inertial cavitation, ultrasound (US) pulses cause bubbles to oscillate nonlinearly
and collapse, producing mechanical forces and potentially thermal and chemical
effects that impact the surrounding tissue. These effects of cavitation can cause
desirable damaging bioeffects in the case of therapeutic targets such as cancerous
tissue. With the use of microbubbles, more effective and predictable lesions can be
produced than when only treating tissue with high intensity US. [1] demonstrated the
useful applications of microbubbles, particularly contrast agents (CA), by showing
that the damage thresholds for lesions created in their presence were lowered because
of the active role that CA served as cavitation nuclei. Not only were lower intensities
required (threshold intensity for a visually apparent biological effect from a single
250 ms burst decreased by a factor of two when microbubbles were in circulation),
but also the threshold for producing nonthermal lesions was also more predictable.
Additionally, as higher intensities were applied, shorter burst lengths of 48 µs were
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required to create lesions with microbubbles present as compared to the 18 ms
required without microbubbles, resulting in a reduction in energy by more than two
orders of magnitude.
In another application, bubbles insonified by long pulses and/or high pulse
repetition frequency (PRF) as considered for imaging or Doppler [2], absorb enough
acoustic energy to cause thermal bioeffects. Wu [3] used continuous wave conditions
to simulate the temperature rise from a Gaussian beam and a perfectly absorbing
disc model for Albunex R© contrast agent. Wu found that temperature rises with
increasing perfusion lengths, time duration, focal gain, and acoustic power. The
highest computed temperature rise was approximately 12◦C for a perfusion length
of 3 mm, 60 s time duration, 1.67 focal gain, and total acoustic power of 110
mW. Applications such as hyperthermia would benefit from the controlled thermal
therapy that microbubbles would provide [4]. Holt and Roy [4] proposed that the
use of bubbles would allow for thermal bioeffects with reduced input energies, which
in turn provides another advantage of reducing heat deposition in overlying tissues.
Both cavitational and thermal methods of bubble-mediated therapy are
compelling arguments for the utility of microbubbles. It would seem even more
advantageous if the spatial locations of these bubbles could be controlled, thereby
dictating the location of the desired therapy. For example, if the target tissue were a
cancerous tumor, the placement of preexisting bubbles in the area of interest would
aid in applying therapy to that specific region. This spatial localization is difficult to
accomplish when restricted to the vasculature as CA are, although some formulations
of CA and droplets may be small enough to be passed into the extravascular space,
particularly in the case of cancer with its higher vascular permeability. Attempts to
produce bubbles in tissue without pre-existing nuclei present may be undesirable or
perhaps counterproductive if the exposures require the application of long durations
and/or high pressure amplitudes to generate bubbles through cavitation activity.
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One way to control the spatial distribution of microbubbles is through the use of
droplets that are subsequently vaporized in situ to form bubbles. As developed by [5],
these droplets, which are used in the experiments presented in this paper, are filled
with dodecafluoropentane (DDFP) liquid and encased in albumin shells. They are
superheated at body temperature and can vaporize during insonification, a process
known as Acoustic Droplet Vaporization (ADV). When unfiltered, droplet sizes
range from <1 µm to 18 µm [6] and produce bubbles that are 20-85 µm in diameter
[7]. However, droplets filtered to <6 µm diameter [6] produce bubbles that are
approximately 15-45 µm [7], compared to the already formed CA bubbles that are on
the order of < 5 µm. Though droplets are not more favorably distributed throughout
the body than CA are, they remain as droplets until insonifcation, whereupon they
vaporize, grow, and have the potential to lodge. Whether it is simply the localized
bubble production or the resulting lodged bubbles, subsequent microbubble-mediated
treatment also becomes localized both spatially and temporally.
The generation of bubbles can be spatially controlled with droplets distributed
in tissue or in the bloodstream, as focused US can specifically target a location and
subsequently vaporize droplets. The bubbles resulting from ADV in the capillary
bed would be trapped where the vaporization occurred, as these bubbles are large
compared to the capillary diameter. Although spontaneous vaporization is possible
(implications discussed in [7], filtering droplets to smaller sizes (<5 µm) reduces
these chances because of increased surface tension. As a source of cavitation nuclei,
in one experiment using the field of a shockwave lithotripter, Miller et al. [8] showed
larger bubbles from ADV to be more effective in producing bioeffects than US
contrast agents (CA). Miller and Song [9] also showed that bubbles created by ADV
persisted in mouse tumors four days after intravenous droplet injections. It is unclear
how long liquid droplets persist in vivo since their longevity in circulation depends
on the type of animal model, the degree in which the lungs filter the droplets [6], and
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their route of excretion, which may be similar to that of perfluorocarbon emulsions
[10].
In this investigation, the vaporization of droplets in tissue-mimicking polyacry-
lamide gels is studied. The manner in which bubble clouds grow due to ADV in
tissue or gel may be in part due to bubbles that scatter acoustic energy. When
several bubbles are insonified, backscatter can cause an enhanced field in areas
adjacent to the pre-existing bubbles, creating conditions favorable for additional
ADV and therefore growth in cloud size. Thus, the concept of a plane of bubbles, or
“bubble wall, can also create an environment where backscatter can cause further
ADV. At the same time, the wall can cause interference in the beam pattern to
diminish pressure amplitudes past the wall, thereby lowering the possibility of ADV
beyond the wall. Bubble generation can therefore potentially be confined, and
consequently, therapy can be localized. Thus the process of bubble cloud generation
and the effects of a bubble wall, including specifically its effect on the threshold for
ADV, are studied. The preliminary results are presented in this chapter.
4.2 Materials and Methods
4.2.1 Manufacturing Polyacrylamide Gels with DDFP
Droplets
DDFP droplets were manufactured according to the process described by [5]. A
solution of bovine albumin (A3803, Sigma-Aldrich, St. Louis, MO) and saline at a
concentration of 4 mg albumin/ml saline was made and vigorously shaken with a
VWR Scientific Vortex Genie (Model G-560). A pipette was then used to distribute
750 µl of the albumin-saline solution into separate vials. Due to rapid evaporation,
liquid DDFP was added to each albumin-saline containing vial according to weight.
After 425 µg (slightly more than the target volume of 250 µl to provide a margin for
evaporation) of DDFP was measured, the vials (Cat. No. 223693, Shamrock Glass
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Co., Seaford, DE) were immediately sealed with a rubber stopper and metal cap
(Cat. No. 224100-094 and 224177-01, Shamrock Glass Co.) to prevent the further
evaporation of DDFP. Lastly, the vials were shaken for 30 s at 5000 cycles/min with
an amalgamator (Crescent Dental Mfg. Co., Lyons, IL).
Polyacrylamide gels (7.5% w/v) were made using a stock solution of bis-
acrylamide (A3449, Sigma-Aldrich, 19:1, 30% w/v) solution diluted with deionized
water at a ratio of 1:3 (bis-acrylamide to water). This solution was degassed for
20-25 min in a vacuum chamber with approximate pressures of 50 mm Hg. The
DDFP droplets were then added to the solution and immediately followed by 10%
ammonium persulphate (A3678, Sigma-Aldrich) and tetramethylenediamine (T8133,
Sigma-Aldrich) to initiate cross-linking. The solution (80-100 ml) was gently stirred
to minimize the reintroduction of gas and poured into a plastic container 5 x 5 cm2
in cross-sectional area. Upon completion of cross-linking (approximately 20 min), a
layer of deionized water was added to the surface of the gels to prevent dehydration.
In order to produce a reasonable number of microbubbles, a concentration of
5000 droplets/ml was used for all gels. The stock droplet solution of 107 droplets/ml
[5] was diluted to 106 droplets/ml, and 5 µl of this diluted solution was added for
each ml of polyacrylamide gel. Gels contained droplets of one of three size ranges:
(1) unfiltered droplets with a mean diameter of 4 µm [5], (2) droplets that were
filtered with a 20 µm and 16 µm syringe filter (Whatman, Maidstone, England) in
series, or (3) droplets that were filtered further by the addition of 8 µm and 5 µm
filters. After using a 5 µm filter, the maximum droplet diameter is 6 µm [6]. The
syringe filters used consisted of filter paper of varying pore sizes contained in housing
compatible for syringe use. Droplet solutions were pushed through these filters, and
larger droplets were eliminated at each filter according the pore size.
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4.2.2 Acoustic Source
An annular array transducer (Imasonic, Besançon, France) was used, which
contains 9 annuli of equal area that are bisected to produce 18 elements. The array
contains a central hole such that the active outer and inner diameters are 145 mm
and 68 mm, respectively. The radius of curvature for the array is 100 mm and is
operated at 750 kHz. The array is driven with custom electronics (photograph of
system seen in Fig. 4.1) where, for these experiments, all elements were driven
in-phase. This produced the nominal focal position assumed for all experiments and
a field calibration, which was performed with an in-house fiber-optic hydrophone
[11]. The data was fit with a third degree polynomial and the resulting range of
pressures is shown in Fig. 4.2.
Figure 4.1: 18-element annular array with associated amplifier.
4.2.3 Experimental Setup
The array was mounted on a motorized positioning system (S83-136-MO motors,
Compumotor; DRP60-1 controller, Parker; 120 V power supply, Daedal-Hannifin
Corp., Rohnert Park, CA), which was used to accurately target locations inside a
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Figure 4.2: Calibration of the 18-element annular array with operating frequency
of 750 kHz and geometric focus of 10 cm. The data were fit with a third order
polynomial. This array is the therapy transducer used to create bubble clouds.
polyacrylamide gel. A 5 MHz phased array (FPA 5 MHz 2B, System Five, General
Electric Vingmed, Milwaukee, WI) was placed inside the center of the annular array
to acquire on-axis images. The gel was mounted in a fixed position in front of the
annular array. The setup is shown in Fig. 4.3a. Fig. 4.3b illustrates another aspect
of the experimental setup and will be described later in this section.
Each gel was exposed approximately 40 times with US, with each exposure placed
in a single different location 5-10 mm apart depending on the size of the resulting
cloud, and varying in pressure amplitude and number of pulses. Three conditions
were studied: cloud generation by US exposure (1) in the absence of a bubble wall,
(2) focused at a previously formed bubble wall, and (3) focused past a previously
formed bubble wall. In Cases 2 and 3, exposures were made 15-60 min after the
formation of the bubble wall. These experiments were performed with droplets of
the various sizes described earlier. A B-mode frame from the central 5 MHz phased
array was captured before and after each exposure, and the images were quantified
and compared in Matlab (The MathWorks, Inc., Natick, MA). The phased array was
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Figure 4.3: Experimental setup. The schematic drawing in (a) shows a side view
of the arrangement for an ADV threshold experiment where the phased array is
used to detect droplets vaporized by the annular array. (b) shows a frontal view of
the arrangement for creating a bubble wall. After making a wall, the gel is then
repositioned to the configuration in (A) for further threshold experiments. The same
holder is used in both cases and is depicted in two views here.
operated at low power with a mechanical index (MI) of 0.4 to minimize its acoustic
effects on the existing bubble wall during exposures from the annular array.
4.2.4 Analysis of B-mode Images
Fig. 4.4 shows three examples of B-mode images acquired from the 5 MHz phased
array used for monitoring bubble activity. Regions of interest (ROI) were defined
for each bubble cloud generated and were then compared with the same ROIs in the
B-mode images acquired before US exposure. Four ROIs were chosen as numbered
in Fig. 4.4 for the three different conditions that were previously described. For
ROIs 2-4, where the bubble wall contributed to backscatter in the acoustic field,
the position of each ROI was chosen to exclude the bubble wall in order to improve
detection of new bubble formation.
Cloud size and average pixel intensity were then determined from each ROI.
First, a threshold requirement for pixel intensity was applied to discern which
pixels constituted part of the cloud and which were background scatter from the gel
containing unconverted droplets. This threshold was determined as two standard
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deviations above the mean pixel intensity in an ROI containing a gel and bubble
clouds. Statistics of the distribution of pixel intensities were not taken into account
in determining the threshold value, though a histogram of the pixel intensities inside
an exemplary set of ROIs, as seen in Fig. 4.5, show that the value is sufficient in
order to eliminate background noise and determine ADV threshold. The number of
pixels above this threshold defined the bubble cloud size. To find the average pixel
intensity, a mean pixel value of the ROI was computed after the thresholding was
applied.
The data were then fit in Kaleidagraph (Synergy Software, Reading, PA). The
data for experiments excluding a bubble wall were fit with three linear lines (Eq. 4.1)
and those including a bubble wall were fit with two lines (Eq. 4.2). The reason for
the two different fits will be discussed subsequently. The equations are shown below,
where y is a characteristic of the cloud (intensity or size), p is pressure, and a1 to a6
are adjustable parameters that define the equation of the line segment. A windowing
rect function wk is multiplied to each line segment and defines the threshold value.
y = (a1 · (p− a2) + a3) · w1 + (a4 · (p− a5) + a3) · w2 + a6 · w3 (4.1)
y = (a1 · (p− a2) + a3) · w1 + (a4 · (p− a5) + a3) · w2 (4.2)
4.2.5 Creating the Bubble Wall
The bubble walls were created as shown in Fig. 4.3b with a 10 MHz linear array
(FLA 10 MHz 1A, System Five, GE Vingmed, Milwaukee, WI) since the ADV
threshold has been shown to be lower at higher frequencies [7]. The MI was 1.2. The
wall was created in the plane orthogonal to the central axis of the annular array. The
imager was mounted on a motorized system to create walls of varying thicknesses.
To create a plane of bubbles and in order to prevent shadowing, the electronic focus
of the imaging transducer was manually moved from the lower region of the gel
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(furthest from the transducer) to the upper (closest to the transducer). The focus
was shifted every 3-5 s when no further ADV was visualized. The imaging plane was
also translated in 0.5 mm steps up to 1 mm in the elevational direction on either
side of the initial position to create bubble walls of 1-2 mm in thickness. As the
imaging probe was translated to a new plane to increase the thickness of the bubble
wall, the method of moving the electronic focus to prevent shadowing was followed
for each plane. Variations in the bubble number density occurred due to variability
in the droplet distribution and possibly inhomogeneities in the gel matrix.
The wall was characterized in terms of its backscattering and attenuation
properties. The experimental setup to determine these characteristics, as shown in
Fig. 4.6, is similar to that shown in Fig. 4.3a, with the exception that the holder was
positioned at a 180 degree rotation about the rod to minimize interference with the
hydrophone. For these measurements, the sound absorbing rubber was removed from
the setup, and a window on the back of the holder was created to allow transmission
of US. A single element passive transducer (Valpey Fisher, Hopkinton, MA) with a
nominal center frequency of 5 MHz and nominal focus of 10 cm placed in the center
of the array received backscatter signals with the associated weighting of harmonic
signals from the bubbles. A hydrophone (NTR Systems, Model TNU100A, Seattle,
WA) operating approximately between 1 MHz and 20 MHz was positioned on the
opposite side of the gel sample to receive the US signals transmitted through the gel.
We note that the carrier frequency of 750 kHz lies outside of the nominal range of the
hydrophone, but only relative measurements are considered for the characterization
of the bubble wall. The annular array was used as the transmit source (driven with
11 cycles or 15 µs pulses, 200 Hz PRF, 3 MPa rarefactional pressures) while the
hydrophone received the transmitted acoustics through the bubble wall, and the 5
MHz passive transducer received the echoes off of the bubble wall. The backscattered
and transmitted signals were recorded from a digital oscilloscope (LeCroy 9384L,
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Chestnut Ridge, NY) from a droplet-containing gel lacking a bubble wall, then
with the focus positioned at a bubble wall, and with the focus positioned distally
to the same wall. The gel was translated in the transverse plane to evaluate the
homogeneity of the bubble wall.
Since the eventual application of the bubble wall is in vivo, these measurements
(and experiments) were made with a low frequency of 750 kHz. Higher frequencies
may show similar or stronger results in attenuating and backscattering properties of
the bubble wall because of off-resonance and/or greater distal attenuation.
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Figure 4.4: Examples of B-mode images taken from a 5 MHz phased array placed in
the center of the annular array. These images were used to characterize bubble clouds
as a function of rarefactional pressure. US exposures for three different conditions
(as labeled) are pictured here, and the ROIs surrounding them (numbered 1-4) are
defined by the dotted lines. The pixels in each ROI were evaluated in terms of pixel
intensity and number of pixels per cloud.
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Figure 4.5: Histogram of the pixel intensity of four gels. Threshold was set at 0.67,
which is approximately two standard deviations above the mean pixel intensity as
indicated by 2 (mean) and → (two standard devations).
Figure 4.6: Experimental setup for the characterization of a bubble wall. The annular
transducer transmitted ∼15 µs pulses at a PRF of 200 Hz and rarefactional pressure of
∼3 MPa. The echoes and the transmitted US were received by the 5 MHz transducer
and hydrophone, respectively. A window in the vertical wall of the holder that was




The parameter space associated with US pulses that can produce ADV is large.
Frequency, PRF, pulse length (and consequently duty cycle), and amplitude along
with their relationship to droplet size and acoustic medium all potentially affect
ADV. To begin to understand the impact of these parameters on the creation
of bubble clouds, only the effects of the number of pulses applied and pressure
amplitudes of these pulses on three ranges of droplet sizes were investigated. Each
pulse contained 15 cycles at 750 kHz for a pulse duration of 20 µs. The PRF was
held constant during all experiments at 100 Hz, which maintained a low duty cycle
(0.2%) and correspondingly low time average power. These pulse parameters prevent
local heating that could arise from higher time average powers, though it has been
shown that increasing the ambient temperature alone up to 60◦C [5] does not cause
droplets to vaporize. It is thus probable that ADV is not due to local heating.
The images presented in this section of the paper were taken with a digital
camera. Before each photograph, the gels were sectioned to reduce the amount of
overlying gel but to include the entire bubble cloud.
As might be expected intuitively, as pressure amplitudes increased, so did the
size cross-sectional area of the resulting bubble cloud. A comparison between the
resulting clouds from pressures of 9.8 MPa and 14.7 MPa peak rarefactional pressures
is seen in Fig. 4.7c and 4.7d. The figure also shows various ranges of droplet sizes
(Fig. 4.7a-4.7c) vaporized with the same pressure amplitude. Both clouds generated
with 9.8 MPa rarefactional pressures in gels with 16 µm and 5 µm droplets are
approximately 7 mm in length (Fig. 4.7b and 4.7c) while the cloud formed from
unfiltered droplets is approximately 10 mm in length (Fig. 4.7a). Measure of length
is defined in the longitudinal direction in all photographs.
Varying the number of pulses does not significantly change the size of the bubble
cloud. Shown in Fig. 4.8, clouds created with rarefactional pressure amplitudes of
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Figure 4.7: Optical images of bubble clouds generated with 200 pulses in 7.5% poly-
acrylamide gels. (a) unfiltered droplets; (b) droplets filtered to 16 µm; (c) droplets
filtered to 5 µm all at 9.8 MPa (rarefactional); (d) 14.7 MPa, droplets filtered to 5
µm. A discussion of the cloud shape is included in the text.
9.8 MPa were approximately 9 mm in length. The cloud created with 20 pulses
(left) takes the characteristic cigar shape of the focal zone whereas the cloud created
with 1000 pulses (right) appears to take the teardrop shape that is typical of lesions
distorted by enhanced prefocal absorption associated with cavitational processes
[12][13][14]. Thus it appears that with 20 pulses, ADV occurs in the focal zone,
where the acoustic field is at its highest intensity. Further distal ADV is prevented
during additional insonification by the shadowing caused by the initial droplets
vaporized by the first few pulses; instead, energy is backscattered, causing the cloud
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Figure 4.8: (left) Image of the cigar-shaped cloud generated by rarefactional pressures
of 9.8 MPa with 20 pulses, and (right) teardrop-shaped cloud generated by 9.8 MPa
with 1000 pulses. Droplets were unfiltered in both cases.
to grow toward the transducer. Since ADV occurs when pressures reach a certain
threshold, it seems unlikely that additional pulses will cause further ADV, and thus,
the cloud eventually stops growing.
When comparing Figs. 4.7 and 4.8, some variability in cloud shape and size is
observed. This may be due to inhomogeneity in droplet and/or bubble distributions
as well as in the gel structure. However, a tendency of growth toward a teardrop
shape exists with increasing amplitudes and pulse numbers.
Observing the growth of these clouds (Figs. 4.7-4.8) shows that ADV occurs
in a backward propagating direction toward the transducer. Considering that
backscattered signals can enhance the proximal field, it seems that backscatter could
help create conditions for ADV. If, perhaps, the scattering bubbles already existed,
spatially localized ADV could occur. In other words, bubbles might be strategically
placed to cause further bubble generation in a controlled fashion. A plane of bubbles,
in particular, can scatter US energy in a way to produce superthreshold ADV
pressure amplitudes in desired locations. This concept of using a plane of bubbles, or
“wall,” is demonstrated in Figs. 4.9 and 4.10. The ability to achieve these conditions
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favorable for the creation and use of a bubble wall in vivo will depend on the tissue
selected, flow conditions, and the appropriate placement of the acoustic field. These
issues are considered further in the Discussion section.
Figure 4.9: Both images show clouds generated by rarefactional pressures of 14.7
MPa with 200 US pulses propagating from the top of the photograph. On the left,
the focus of the annular array is positioned on a nominally 1 mm wall, where some
leakage occurs. On the right, the focus is positioned past the wall, exposing the
bubble wall to the lower prefocal amplitudes, which are less likely to leak through the
wall.
Fig. 4.9 shows two US exposures of 14.7 MPa pressure amplitudes in a gel
containing droplets with interference from a nominally 1 mm thick bubble wall. The
image on the left shows the resulting cloud when the focus, where the amplitude
is the greatest, is positioned at the wall. With these high amplitude pulses,
some leakage and ADV occurs past the wall. The image on the right shows that
when focused past the bubble wall, leakage is less likely to occur because pressure
amplitudes roll off prefocally and the wall is more effective at preventing leakage
when it coincides with the location of the lower prefocal pressures.
Distal ADV may be prevented by increasing the backscatter and attenuation of
the bubble wall, properties which can be varied by increasing the thickness and/or
density of the wall. However, since density is dictated by the already high droplet
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Figure 4.10: Optical photographs demonstrating the effects of a bubble wall created
in a gel with droplets filtered to 5 µm. Pressure amplitudes for each exposure is the
same for a given photograph and are stated as follows: (A) 1 mm thick bubble wall,
9.8 MPa; (B) 2 mm thick wall, 9.8 MPa; (C) 2 mm thick wall, 14.7 MPa (D) 2 mm
thick wall, 14.7 MPa. The numbers indicate the sequence of US exposures, where
the focus of the therapy array (annular transducer) is first translated laterally from
positions 1 to 2, and then axially from 2 to 3. The direction of US propagation is
from the top of all photographs. Locations labeled 1 correspond to exposures in the
absence of a bubble wall, those labeled “2 correspond to exposures focused past a
wall, and those labeled “3 correspond to exposures focused in front of a wall.
concentration used in these experiments, only wall thickness was changed. Fig. 4.10
compares the size and shape of bubble clouds in the presence of ∼1 and ∼2 mm
thick bubble walls. Three cases, as numbered in Fig. 4.10, were demonstrated in
the same gels in the following order: a 200 pulse US exposure (1) in the absence
of a wall (left side), (2) focused past a wall (translated only laterally to the right,
where the circles indicate the location of the focus), and (3) focused in front of the
wall (subsequently translated only axially toward the transducer). The images show
these three cases side by side in the same gel, where the direction of US propagation
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is from the top of each photograph. Figs. 4.10a and 4.10b show all three cases while
Fig. 4.10c and 4.10d show the first two.
The clouds created in Fig. 4.10a and 4.10b were vaporized by the same
rarefactional pressures of 9.8 MPa with the varying parameter being a difference in
wall thickness, where the nominal thickness in Fig. 4.10a is 1 mm and that of Fig.
4.10b is nominally 2 mm. Figs. 4.10c and 4.10d show two examples of clouds created
by larger pressures of 14.7 MPa and show how they are affected by 2 mm thick walls.
For smaller rarefactional amplitudes of 9.8 MPa, a 1 mm thick wall is sufficient
to prevent ADV past the wall (Fig. 4.10a, Case 2) as is a 2 mm thick wall (Fig.
4.10b, Case 2). However, a 1 mm wall is of insufficient thickness to completely block
pulses of higher amplitudes, as demonstrated previously in Fig. 4.9, while a 2 mm
wall (Fig. 4.10c) shows that it is effective in preventing ADV on the distal side
of the wall with US of higher amplitudes. In essence, the wall seems to serve the
same purpose as the bubbles created during the first few US pulses; both create
backscattering conditions that cause ADV propagation back towards the transducer.
It is necessary, though, that the plane of bubbles be large enough to span the beam
of the transducer to provide sufficient interference. Fig. 4.10d (Case 2) shows that
US can still cause ADV to occur if it propagates partially around the side of the wall
without any aberration.
Fig. 4.10c shows that while there is distal shielding, ADV still occurs on the
proximal side of the wall (Case 2) due perhaps to the backscattering and the
resulting enhanced field. Because of this cloud formation, exposures in which the
US was focused in front of the bubble wall were not performed in the experiments
seen in Figs. 4.10c and 4.10d. Additionally, US with rarefactional pressures of 9.8
MPa focused on the proximal side of the bubble wall (Figs. 4.10a and 4.10b, Case 3)
create bubble clouds that are larger at the base (near the focus) than those created
in the walls absence (Case 1). This may be accounted for by the post-focal beam
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reflecting off of the bubble wall, creating superthreshold pressure conditions on the
proximal side of the wall to cause further ADV and therefore enlarge the cloud base.
4.3.1 ADV Thresholds
Plots shown in Fig. 4.11 illustrate quantification of the threshold level of ADV for
three cases for gels with droplets with wall and focus cases as follows: (1) no bubble
wall, (2) with US focused at a bubble wall, and (3) with US focused distal to a
bubble wall. The extrapolated threshold values are listed in Table 4.1. These cases,
all with exposure to 200 pulses, were performed for droplets filtered to 16 µm and
for 5 µm to investigate the impact of size on bubble wall properties and thresholds.
The data were obtained from B-mode US images taken from the 5 MHz phased
array placed in the center of the therapeutic array as was described in Fig. 4.4.
Table 4.1: Summary of threshold values extrapolated from curve fits.
US focused
Threshold Gel containing US focused at distal to wall,
detection droplets bubble wall (MPa) ROI proximal
method (MPa) (MPa) to wall (MPa)
5-µm droplets
Cloud size 7.51±0.02 3.93±0.50 11.61±0.81
Pixel Intensity 7.53±0.18 4.17±0.42 11.63±0.80
16-µm droplets
Cloud size 7.50±0.15 3.53±0.78 9.91±1.89
Pixel Intensity 7.79±0.01 3.97±0.21 9.79±3.94
Values indicate the best fit approximation ± standard error values. In the case of analyzing an ROI
at the focus with a prefocal bubble wall in place, the curve fits are almost completely linear, making
distinguishing a threshold value unclear.
As previously mentioned, the data were fit to either two or three line segments
(Eqs. 4.1 and 4.2), the reasons for which are discussed here. Three line fits are
required when no bubble wall is present because the first droplets that are converted
to gas bubbles vaporize in the spatial peak of the acoustic field, the focus. The
spatial extent of the focus occupies a certain volume, thereby causing perhaps a
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localized group of the droplets to vaporize at approximately the same time, a process
that can be reflected in the jump in cloud size around the ADV threshold. This may
not be the case with the presence of a scattering bubble wall, where the data lacks
the jump apparent in the aforementioned data. In this case, a two-line regression fit
the data well, as there was no step function at the threshold for detectable bubbles.
Because existing bubbles interfere with the acoustic field of the annular array, it
is possible that the field of the imaging phased array could be disturbed as well. To
confirm echoes that may originate from the proximal side of the bubble wall, further
B-mode images were taken with a 10 MHz linear array during some experiments,
where the transverse plane was oriented along the axis of the annular array. Fig. 4.12
shows the results from such an experiment for droplets filtered to 16 µm (Fig. 4.12a)
and 5 µm (Figs. 4.12b and 4.12c). Average cloud pixel intensities were analyzed
from the 5 MHz phased array and 10 MHz linear array and roughly correspond,
though discrepancies may occur due to the different point spread functions, speckle
patterns, and viewing directions of the two imaging probes. Individual data points
demonstrate the variations that may occur in the bubble wall and how it may affect
ADV when pressures are above the threshold. Fig. 4.12a shows the results from one
experiment, and Fig. 4.12b and 4.12c both show data from a second experiment
with the smaller sized droplets.
4.3.2 Characterization of Bubble Wall
As shown in Fig. 4.13, the increase in mean backscatter when the bubble wall
is formed in the gel is approximately 25.5 dB and 22.7 dB for the two locations of
the focus. The higher backscattered signal when focused at the bubble wall (Fig.
4.13a) is most likely due to the high amplitudes in the focal zone that are reflected
back off the wall, whereas moving the focus past the wall (Fig. 4.13b), will reflect
lower prefocal amplitudes in the beam. Both cases show a maximum backscatter of
106
approximately 40 dB and the minimum to be almost 0 dB, indicating an apparently
large variability in bubble density and/or bubble size distribution. Values expressed
in dB are relative to backscatter and attenuation measurements made in a gel with
unvaporized droplets.
Measurements of the transmitted signals show similar mean attenuation of
12.4 dB and 12.5 dB as well as similar standard deviations of 4 to 5 dB when
focused at the bubble wall (Fig. 4.13c) and when focused past the wall (Fig.
4.13d), respectively. Maximum attenuation values are approximately 27 dB, though
non-attenuating areas are also present.
Though US is backscattered and attenuated similarly on average for both
positions of the focus with respect to the bubble wall, it appears that focusing past
the bubble wall defocuses the beam. Thus the spatial distribution of wall attenuation
is more uniform (Fig. 4.13d), as evidenced by the fewer finely defined areas of
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Figure 4.11: Plots of cloud size and intensity as a function of rarefactional pressure
for two droplet distributions. Data were taken from B-mode images from a 5 MHz
phased array, where the imaging and therapeutic planes were aligned. Both size and
intensity increase with pressure, indicating that the overall cloud size grows as well
as the echogenicity.
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Figure 4.12: Results from experiments involving a prefocal bubble wall. The plot
in A shows data from focal ROIs with 16 µm filtered droplets, and B and C show
averaged data from focal and proximal ROIs, respectively, with 5 µm droplets. B-
mode images were taken from an on-axis 5 MHz phased array (axial view) and a 10
MHz linear array, where the transverse plane was oriented parallel to the axis of the
annular array (coronal view). Data from the two imaging probes confirm that the
bubble wall can both reflect and consequently shield distally. Data points illustrate
the variability that can occur in bubble walls and their resulting efficacy in serving
as a shield, at least with high pressure beams.
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Figure 4.13: Backscattered and transmitted signals from and through a ∼2 mm thick
bubble wall. The results are shown for two cases: (A, C) the focus of the annular array
is positioned at the bubble wall , and (B, D) the focus is positioned approximately
1 cm past the bubble wall. In the comparisons of the backscattered signals (A, B),
bright regions indicate high backscatter, and in the comparison of the transmitted
signals (C, D), bright regions indicate high transmission. Signals in dB are calculated
relative to the backscattered and transmitted signals from a gel with no bubble wall.
The top sidebar indicating the dB scale corresponds to backscattered signals (A, B),
and the bottom sidebar corresponds to transmitted signals (C, D).
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4.4 Discussion
Both the size of the bubble clouds and threshold for ADV can change with the
presence of a preexisting bubble wall. It appears that backscattering and the resulting
field pattern generate pressures sufficient to cause ADV. Without the presence of
a bubble wall in both size ranges of droplets, ADV occurs at approximately 7.6
MPa on average at this low, 750 kHz frequency, while the placement of a bubble
wall in the focus produces ADV at applied pressures of approximately 3.9 MPa on
average. The reduction in transmitted pressures is approximately half and seems to
suggest that some constructive interference is occurring at least locally and even if
the scatter from the wall is incoherent. Preexisting bubbles apparently enhance the
proximal acoustic field, creating an environment that enhances the ADV effect or
enables the achievement of a desired effect with approximately half the acoustic input
originally required. In addition to constructive interference, harmonic backscatter
from the bubbles may play a role, as the threshold for ADV decreases with increasing
frequency [7]. Though pressures here could achieve an MI of ∼4 when using a bubble
wall as compared to 1.9 as allowed by the Food and Drug Administration [15] for
diagnostic purposes, we only propose these methods for therapeutic use for which
the possibility of collateral damage may be acceptable to achieve the desired results.
The bubble wall can also serve as a protective layer, as simulated in these
experiments where the bubble wall is prefocal. There is no apparent threshold for
distal ADV as seen in Fig. 4.11 for the case of prefocal placement of the wall and
ROIs placed at the focus. However, if the wall is not extensive enough to obstruct the
lateral beam width, it is possible that ADV will occur at the focus (Fig. 4.10d). For
higher pressures, increasing the wall thickness and/or bubble density can increase
attenuation and backscatter. The effectiveness of the existing wall depend on the
incident US since high pressures can still cause distal ADV if the attenuation and
backscattering are not sufficient.
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It would appear that when droplets are filtered to 5 µm (versus 16 µm), the
bubble wall, when placed in the prefocal beam, is more effective in preventing ADV
on the distal side and also in reflecting back energy to cause ADV on the proximal
side. When examining cloud size, US pulses of 19 MPa produce clouds of 0.8 cm2
cross sectional area in gels with 5 µm droplets (Fig. 4.11a, ROI proximal to wall)
and 0.05 cm2 in gels with 16 µm droplets (Fig. 4.11c, ROI proximal to wall). The
increased effectiveness of the bubble wall from 5 µm droplets may be due to a higher
and more uniform bubble density.
Increasing the thickness and density of the wall can reduce the inhomogeneities
found in thinner walls. A 2 mm thick bubble wall can vary by 4 and 6 dB in
attenuation and backscatter (Fig. 4.13), respectively, thus affecting the ability to
vaporize droplets on the proximal side and to prevent ADV on the distal side. The
presence or absence of droplets in a particular location dictates the possibility of
a vaporization event. The irregular distribution of droplets within the gel affects
the creation of the bubble wall and also the creation of subsequent clouds. These
issues need to be considered when using a bubble wall as a shield or as a reflector,
since generating clouds with transmitted sub-threshold US requires sufficient
backscatter. In order to successfully take advantage of the constructive interference
patterns, droplets must be located in proximity of the focus because the resulting
super-threshold volume is small.
While the structure of a bubble wall may be achievable in a tissue-mimicking
gel, its ideal form will be more difficult to attain in vivo. For example, consider
the situation of the vascular bed within perfused tissue. The spatial distribution of
accumulated bubbles resulting from ADV will depend on many factors including the
portion of the bed spanned by the acoustic field and the droplets vaporized within
it. In capillaries, bubbles produced by ADV may become lodged as they are larger
than the capillary diameter. If the bubbles are not large enough to immediately
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lodge, they can lodge downstream, spreading the thickness of the wall, or lodge
even further downstream into vasculature where their diffuse distribution does not
substantially contribute to wall formation. Bubbles that are generated in the veins
may also exit the insonified area and would not contribute to the wall at all. The
lodging or containment of these bubbles in the structure of the wall may result in a
higher bubble density in highly perfused tissues such as in the kidney and liver.
A second area of interest is tissue. Droplets can become extravascular if they
pass through leaky capillaries, like those found in tumors or otherwise removed from
the vascular system such as by the reticulo-endothelial system of the liver. In this
case, a bubble wall can be created in a similar fashion as those in the experiments
in this paper, but it is uncertain if the homogeneity in the distribution of droplets
is adequate to produce a wall that is capable of acoustic field enhancement and
shielding. The preliminary results presented in this paper in an in vitro environment
are promising for in vivo application, though further investigation is needed.
4.5 Conclusions
The backscattering properties of microbubbles can augment or obstruct the sound
field in the affected area. Constructive interference due to these effects reduces the
transmitted pressures required for ADV, and the attenuation from these bubbles can
create a protective boundary for distal areas. The potential result can be a defined
area for therapy created by low pressures and amounts of energy. However, it is also
important to take into account properties of the backscattering bubbles and how
their spatial uniformity may affect subsequent US exposures.
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Conclusions and Future Work
5.1 Summary of Thesis Contribution
5.1.1 Introduction
The collected work presented in Chapters II-IV contribute to the transition of
embolotherapy by acoustic droplet vaporization (ADV) to the intended in vivo
conditions. Much of the fundamental science underpinning the manufacturing and
behavior of droplets in response to an acoustic field was explored in a series of
published journal articles [1][2][3]. The information gleaned from these findings
forged the way to successful application of concept and execution in a small animal
model [4].
However, in translating these findings to a larger animal model that is on the
scale of human beings, additional issues needed to be addressed. The attenuation
from overlying layers is a constant issue in any type of ultrasound, and likewise,
it must be contended with here. Knowing that ADV is achievable in vivo but
without any overlying tissues, two avenues can be approached: (1) ensure that the
therapeutic transducer has enough acoustic power to achieve the necessary in situ
pressures, and (2) to devise a strategy to reduce the necessary pressures for ADV. A
single transducer may not have the capacity to effectively treat the high variability
of patient types; therefore, tackling the latter solution is the simpler, less expensive,
and perhaps more elegant approach.
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Therefore, this dissertation explored strategies to reduce the requisite pressures
for ADV. First, the role of inertial cavitation (IC) in ADV was investigated and
then in turn, IC was induced, via the disruption at low amplitudes of ultrasound
contrast agent (CA) to try to trigger ADV. This strategy involving CAs was then
tested under in vitro transcutaneous conditions, where both threshold pressures were
measured and droplet conversion efficiency was evaluated. A different strategy in
which prudent targeting of droplets already situated in either the capillary bed or in
tissues created spatially localized microbubbles. These microbubbles were found to
serve as a “bubble wall,” which could prevent further distal ADV and at the same
time, could reduce the acoustic output necessary for proximal ADV.
5.1.2 Experimental Conclusions
Acoustic Droplet Vaporization: Effects of Pulse Duration and Contrast
Agent
The role of IC in ADV was explored by a series of experiments that examined the
effects of pulse duration from microsecond to millisecond pulses as well as the effects
of ultrasound contrast agent (CA). ADV, contrast disruption, and broadband noise
emissions, which are the acoustic signature of IC, were detected and compared for
correlation to each other.
It was found that at 1.44 MHz, an almost bimodal relationship existed when
pulse durations for single pulses ranged from 20 µs to 20 ms. ADV thresholds
(as detected by B-mode US) were relatively constant until they dropped for pulse
durations lasting longer than 1 ms. Repetitive 20 µs pulses had the same ADV
threshold as single long 20 ms pulses when total on-time remained constant. The
thresholds for broadband noise followed similar trends as the thresholds for ADV,
as well as similar values of pressure. There has been no indication that any further
change in broadband noise threshold exists for pulse durations lasting longer than
20 ms [5][6], the longest duration tested in these experiments. Therefore, it was
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concluded that IC played a role in ADV, although it remains undetermined in what
capacity.
The addition of CAs verified that IC external to a droplet can be a mechanism
of ADV. CA concentrations from 103, 104, and 105 microspheres/mL all reduced
the threshold by an order of magnitude when 20 ms pulse durations were used.
Although the probability of ADV was the largest with the highest concentration of
CA, the actual differences in threshold were modest. The decrease in ADV threshold
with CA was less substantial with 20 µs pulses, which reduced the threshold by
a factor of three (9.5 dB). Nonetheless, this reduction in threshold is appreciable
when considering the amount of attenuation that is expected when treating a target
transcutaneously, which is 10.75 dB on average for the human abdominal wall [7].
Attenuation and Efficiency Considerations in Acoustic Droplet Vaporiza-
tion for Embolotherapy
The relationships found between ADV threshold and contrast agent were
reconfirmed in the next set of experiments. A different transducer with a 1 MHz
operating frequency, higher focal gain and greater power was used for its capability
to be able to reach a target at depth for ADV.
It was found that approximately the same amount of power was necessary to
achieve ADV through a water path as it was through an attenuating tissue-mimicking
(TM) phantom when CA were added. Repetitive pulsing with 10 µs pulse durations
were used for these experiments. When comparing pressures necessary to achieve
the desired effect, the rarefactional pressure appeared to be the salient determinant
of ADV. Although high frequencies are able to vaporize droplets more easily when
propagating through a water path [1], the higher harmonics did not appear to be
significant contributors in the presented results.
Pulse repetition frequency (PRF) was found to play a pivotal role in the efficiency
of droplet conversion when only droplets were present and also when they were
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combined with CA. In either case, an optimal PRF was apparent. When droplets
were combined with CA, a low PRF was necessary such that a new supply of CA
would be replenished within the acoustic beam. When amplitudes increased above
the measured threshold, the effective volume above threshold also increased as the
portion of the acoustic beam that was at amplitudes above threshold expanded. Since
the threshold for inertial collapse of CA was much lower than the ADV threshold,
the effective disruption zone for CA was larger than the effective vaporization zone
for droplets when amplitudes were at or above ADV threshold.
Absent of any CA, an optimal PRF was also found. When PRFs were too high,
bubbles that were visualized through B-mode US in the focus of the vaporizing
transducer were absent downstream. Orthogonal imaging planes confirmed that
the disappearance of bubbles was not due to radiation force. Previous experiments
showed that at a higher frequency, an optimal PRF was not apparent [8], but
instead, there existed an exponential rise with PRF with eventual saturation.
A hypothesis was proposed to explain these findings. Several papers in the
literature [9][10][11][12] theoretically developed and experimentally tested the
pressure threshold for inertial collapse of bubbles for a given insonating frequency,
bubble size, ambient pressure, ambient temperature, and attained temperature at
collapse. These works assessed the likelihood of cavitation for diagnostic US. When
applying this theory to the bubble sizes expected from the droplet size distribution
to be used in vivo, it was found that most of the bubbles would have been destroyed
when pressures exceeded the ADV threshold. Thus, there are competing phenomena
when PRF is too high; the bubbles created by ADV can be subsequently destroyed
with the next US pulse. For a 1 MHz center frequency, the threshold for inertial
collapse for a 60 µm bubble at 3 MPa Pr is lower than the ADV threshold at 3.8
MPa Pr.
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Spatial Control of Gas Bubbles and their Effects on Acoustic Fields
Droplets can be vaporized in the vasculature, or for some droplets of smaller size,
they can pass through leaky vessel walls and traverse into the tissue. Discussion thus
far has concentrated on the vaporization of droplets in feeder arteries, but it does not
preclude the possibilities of targeting other areas. In fact, targeting in areas such as
capillary beds or in droplet-embedded tissue can be advantageous as it enables the
ability to guide bubble placement. In capillaries where the diameter is small and in
restricted environments such as the tissue, an ADV event could create a bubble that
would more or less lodge in its present location. Manipulation of bubble placement
could then be used for further therapeutic purposes.
The behavior of ADV in a constrained environment was explored in a
polyacrylamide gel. It was found that the bubble clouds generated in the gel
matrix resembled the types of lesions documented previously in other experiments
[13][14][15]. Few pulses (∼ 20 cycles) created bubble clouds resembling a cigar shape,
while additional pulses would cause the bubble cloud to resemble a tear drop. It
was observed that after the formation of a cigar shaped bubble cloud, further ADV
would occur proximally and cause the bubble cloud to grow toward the transducer.
It appeared that shadowing occured after the creation of the first bubbles, and
subsequent acoustic pulses were backscattered.
Thus, the same effect was artificially devised. A bubble wall, which was created
in the lateral plane of and prior to insonation by the vaporizing transducer, created
an environment of shadowing distal to the wall and of backscatter proximal to the
wall. It was found that the bubble wall, with diminished distal fields, could serve as a
protective barrier against further distal ADV. The backscattered energy enhanced the
proximal acoustic field, enabling proximal ADV to occur at approximately half the
applied pressures necessary when no bubble wall was present. When focusing distal
to the bubble wall, it was found that some “leakage” could occur through the wall
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when insonating at higher amplitudes. However, increasing the thickness of the wall
prevented these effects. Thickness, expansiveness, and homogeneity of the bubble
wall affected its efficacy as an acoustic shield and enhancer. However, despite the
variability found within a thicker (∼2 mm vs. ∼1 mm) bubble wall in backscattered
and transmitted signal, it appeared that ample constructive interference occurred to
consistently enhance the acoustic field for subsequent vaporization with lower energy
input.
Summary of Results
Transcutaneous in vivo ADV can be effective. When optimizing the process,
careful consideration must be taken when designing pulse parameters and treatment
strategy. The results from this dissertation are summarized below:
• ADV threshold decreases with acoustic exposure.
• ADV threshold decreases with the addition of CA. With long pulses, the
introduction of CA can decrease the threshold by an order of magnitude,
whereas with short microsecond pulses, CA can decrease the threshold by a
factor of 2-3.
• ADV threshold is dependent on in situ peak rarefactional pressure.
• The relationship between PRF and maximum efficiency for droplet conversion
when only droplets are present appears to be frequency dependent. At low
frequencies, an optimal PRF exists. At high frequencies and below the
threshold for inertial collapse, efficiency increases with PRF until bubble
production saturates.
• There is an optimal PRF for maximum efficiency when droplets are combined
with CA.
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• Lodged bubbles produced by ADV can behave as a shield and reflector for
further US therapy. Choice of a target artery or volume is important in order
to prevent obstruction of further US treatment. Location of an ADV bubble
wall can also create an advantageous acoustic field such that less pressure is
required for further proximal US treatment.
5.2 Future Work
5.2.1 Further investigation of the Mechanisms of ADV
The mechanisms for ADV are not fully understood. We have found that inertial
cavitation (IC) can occur within and outside of the droplet [5], each of which
triggers a vaporization event. As summarized in the previous section, it was shown
in Chapters II and III that IC external to a droplet could trigger ADV via the
inertial collapse of CA microbubbles. In the absence of CA, evidence from high
speed photography (Fig. 5.1) shows that for large droplets on the order of 344 µm
in diameter, nucleation sites do occur within the droplet, ultimately forming a gas
bubble. However, for these large droplets, these nucleation sites do not trigger the
vaporization of the entire droplet. Instead, the droplets become biphasic; it contains
both a liquid and gas within it. For smaller droplets (18-45 µm in diameter),
dipole motion and gas inception was seen also through high speed photography [3].
However, it was not proven that these nucleation sites emerged from within the
droplet, as the bubbles may have been superimposed and may have laid outside
of the lateral plane (with respect to the camera) of the droplet. In the case for
the larger droplet, the bubbles coalesced within the droplet itself, implying that
nucleation occurred within the droplet.
The difference between the two mechanisms may lie in the relationship between
droplet size and wavelength. As frequency increases, the acoustic wave has more
interaction with the droplet, as exhibited by the dipole oscillation that occurs in
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0.0 ms 0.045 0.136
0.454 3.319 7.272
Figure 5.1: ADV of a 344 µm droplet. The duration of insonation is approximately
10 ms and begins with the first frame at 0.0 ms. Images are taken with a high speed
camera. Data was presented at [16].
sync with the acoustic pulse [3]. We do not yet have any evidence as to what occurs
during ADV at low insonating frequencies when CA are not present.
However, it was shown in Chapter II that aggregates can form at low frequencies
for long pulse durations or “on-time.” In this case, aggregates may have behaved like
a large droplet, and perhaps the collective size allowed for more interaction with the
ultrasound. If the albumin proteins were not fully cross-linked on the shell of a single
droplet, they could even have cross-linked with proteins from neighboring droplets
within the aggregate. The ultrasound wave could interact with the droplets as an
aggregate as well as individually, with each droplet imposing mechanical forces on
the other. These aggregates could perhaps be compared to work by Matsumoto et
al. [17], who have shown that individual bubbles interact with each other in a bubble
cloud to generate a collapse with higher energy than individual bubbles collapses.
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These clouds have a lower resonant frequency than the bubbles that comprise it.
Likewise, for a given low frequency and pressure amplitude, there could in fact
exist a “critical” size for aggregation that allows for interaction with the ultrasound
wave and subsequent vaporization. The relative size of these aggregates to the
insonating wavelength could be compared to the relative size of a single droplet
with a wavelength at a higher insonating frequency, such as the droplet imaged
in Kripfgans et al. [3], which vaporized in the absence of surrounding droplets.
Using Stokes law and given the rate that the aggregates are falling, the size of
the aggregates can be calculated. For repetitive pulsing at below ADV threshold
amplitudes (Chapter II), calculated aggregate sizes ranged from 118-150 µm in
diameter. Further investigation must be conducted to evaluate what aggregate sizes
are necessary for vaporization and at what pressures.
Whether this aggregation occurs in a flow environment remains unknown for
these acoustic parameters, and thus it is undetermined whether aggregates are a
necessary component of ADV. An experiment much like those performed in this
dissertation, with the exception of a horizontally oriented flow tube rather than a
vertically oriented tube, may allow for differentiation between aggregated droplets
that would sink to the bottom of the tube from buoyant bubbles that would rise
to the top of the tube. Gradually increasing the flow speed from a standstill while
maintaining an amplitude known to produce aggregates may also reveal whether
aggregates can form in flow and at what flow rates they’re visible through B-mode
ultrasound. Using microscopy, it has been shown that CA microbubbles form
transient aggregates in flow due to the presence of pulsed ultrasound [18]. It remains
to be determined whether this would occur with droplets under flow condition tested
here or in vivo.
Investigation of the behavior of perfluorocarbons (PFCs) of higher boiling
points (BP) may further elucidate the mechanisms at play in this vaporization
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process. PFCs of higher boiling point would make more stable droplets as the level of
superheat is not as high if not nonexistent. If IC external to the droplet is responsible
for triggering a vaporization event, then ADV threshold could be the same for
either dodecafluoropentane (DDFP) droplets (BP = 29◦C) or droplets of another
PFC, such as 1,1,2-trichlorotrifluoroethane (BP = 47-48◦C) or perfluorohexane (BP
= 58-60◦C) if vaporization occurs at all. If vaporization does occur, it should be
temporary, and the PFC should return to liquid phase. As PFCs with higher BP
than the ambient temperature (either room or body temperature), they may not
undergo phase transition at all. In this case, passive acoustic detection of broadband
noise would determine if IC occurred. The amplitudes at which IC occurs for these
high boiling point PFC droplets can be compared to those found in Chapter II if
the same transducer is used and if the droplets are of the same size distribution
and concentration. A secondary study may be required to understand the droplet
yield from manufacturing different PFC droplets as it has been shown that ADV
threshold decreases for larger droplets [3] and IC threshold decreases with increasing
concentrations of nuclei [19].
5.2.2 Effects of the Inertial Collapse of CAs on ADV
On the same note, it would be beneficial to understand the direct interaction
between CA and droplet. The inertial collapse of CA can trigger a vaporization
event, but it is undetermined how they interact. From these initial exploratory
experiments, it was found that a small amount of CA in comparison to the amount
of droplets that were present was required to achieve the desired effect. It would be
beneficial to understand the ratio required for optimal droplet conversion.
A simple solution can be employed to understand the mechanism between droplet
and CA. Because the CA concentrations tested in this thesis were above the apparent
minimum quantity of CA necessary to facilitate the ADV process, the ratio of the
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two agents can be further adjusted to ascertain the threshold concentration. Given
a certain droplet concentration, what is the minimum number of CA microbubbles
required to trigger a detectable ADV event? In other words, how many droplets can
the collapse of one CA microbubble affect?
Since the concentrations of each agent are known, the average distance between
each droplet and CA can also be calculated assuming a homogenous distribution.
For the concentrations used in Chapter III, the average distance between a CA
microbubble and its surrounding droplets was approximately 86 µm. In this manner,
minimum proximity of the agents can be measured. The required proximity can be
estimated by lowering the concentration of both droplets and CA but at the same
time maintaining the ratio of the two agents. The ADV threshold measurements
with CA in this dissertation provide a baseline ratio of concentrations. Reducing
the concentrations increases the average distance between agents, and the threshold
quantity to trigger ADV would indicate the minimum distance necessary between
CA and droplet.
This measurement of minimum distance between CA microbubble and droplet can
perhaps provide insight into the mechanisms involved. Several events accompany an
inertial collapse including high temperatures at the core, jet streams, and secondary
shock waves. Jet streams are formed from asymmetrical collapses when bubbles
are near a solid surface and cause considerable local damage to the surface [20].
Although droplets cannot be considered a solid surface, they may behave similarly to
a bubble, which imposes secondary Bjerknes forces on a neighboring bubble. Thus,
this interaction between CA and droplet may promote an asymmetrical collapse and
the formation of jet streams, and requires that the two agents be in close proximity.
This jet stream may then, due to its proximity, be able to disrupt the albumin shell of
the droplet, exposing the previously encapsulated superheated liquid to the medium
for subsequent vaporization. However, if secondary shock waves are responsible for
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or act as an additional perturbational source for triggering an ADV event, the two
agents may not need to be as close. The statistics involved in chance collisions or
even movement to the appropriate proximity must also be taken into consideration.
It is possible that one chance vaporization event could launch a cascade of events.
High speed shadowgraphy is an ideal option to capture such situations when, for
example, (1) microbubble and droplet are situated close together, (2) microbubble
and droplet are situated farther apart, and (3) when two droplets surround one
microbubble. High speed shadowgraphy would provide direct visual evidence of the
interaction between the inertial collapse of a CA microbubble and a surrounding
droplet, where both jet streams and shock waves can be perceived (Fig. 5.2). Aside
from visualizing the consequences of an inertial collapse, if a jet stream disrupted
the CA shell, the resulting events leading to the vaporization of a droplet would look
much different than a droplet’s response to a sound wave, where nuclei can form
within the droplet (Fig. 5.1) or dipole oscillation may occur [3]. Likewise, similar
behavior could occur if a secondary shock wave were emitted from the inertial
collapse of a microbubble. Shadowgraphy would also reveal if a combination of the
two is necessary. Positioning of the CA and droplet in the field of view may be
difficult; however, laser induced optical breakdown (LIOB) has been previously used
to create bubbles in precise locations [21] and can be used as a tool in this case to
create bubbles in desired locations with respect to preexisting droplets.
An additional experiment can be performed to test the hypothesis that the
inertial collapse of CAs causes ADV by means of disrupting the albumin shell.
Under current conditions where ADV occurs in saline, it is possible that the shell is
disrupted and that the consequent vaporization occurs before the shell can repair
and cross-link again. If this is the case, then an experiment can be designed to allow
optimal conditions for shell repair; a medium saturated with albumin may provide
the necessary building blocks for the albumin shell to repair before vaporization. If
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saturating the medium with albumin significantly alters the ADV threshold, it would
appear that shell disruption is the mechanism for ADV with CAs. However, a minor
shift in threshold may only be a result of a change in the medium’s viscosity due
to high albumin concentration. In order to compensate for this potential difference,
acoustic emissions can be monitored and used as a feedback mechanism to adjust
the level of cavitation activity such that it is the same in both saline and in a high
albumin medium. Once the level of cavitation activity, or amount of “trigger,”
is matched, any differences in ADV threshold can be attributed to the change in
shell properties. Alternatively, modifying the shell composition of the droplet and
measuring changes in the ADV threshold would also demonstrate the role of shell
disruption in ADV.
Figure 5.2: Zhong et al. produced high speed shadowgraphs of the inception and
collapse of bubbles produced by a shock wave generated by a shock wave lithotripter
[22]. The numbers at the top of the images indicate frames captured at 164, 245, 600,
and 1100 µs after spark discharge. A microjet is seen at 164 µs and is marked by “J.”
Bubble growth and/or coalescence are seen at 245 and 600 µs, and secondary shock
waves are seen at 1100 µs.
5.2.3 Optimization
The work presented in this dissertation investigates the effects of acoustic
parameters that will aid in being able to cause ADV in vivo transcutaneously.
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However, further experimental work can be done to refine the value for optimal PRF
for any given beam width and flow rate. It may be more advantageous to insonate
at a higher frequency if it allows more frequent pulsing, in which case a large beam
width would also be favorable. However, at these higher frequencies, increasing
the pressure amplitude could also enter the regime where ADV bubbles could
collapse. An in-depth investigation of efficiency as it relates to carrier frequency,
amplitude, beam width, and its optimal PRF would be extremely beneficial to
in vivo applications where rapid occlusion and maximum droplet conversion are
desirable.
5.2.4 Targeted Droplets
Targeted Droplets for Drug Delivery
Targeted agents including CAs have been the subject of recent scientific research
for effective cancer therapy [23][24][25]. Likewise, the ability for great specificity
would improve the efficacy of ADV in therapy. Development of droplets for targeted
drug delivery is ongoing and aims to manufacture targeted drug-bearing droplets
that would release the drug only during ADV to a specific site. Concurrent vascular
occlusion could further localize the drug therapy. Incorporation of Paclitaxel into a
droplet and its subsequent vaporization has already been successful [26][27].
Biphasic agent
As droplets can be targeted with appropriate ligands for drug delivery, CA can also
be paired with the droplets in a similar manner. Since it has been shown that the
insonation of CA microbubbles can trigger ADV, it may be possible to combine the
two agents such that each droplet is bound to a microbubble. The incorporation of a
microbubble into the droplet may be another alternative [28], but the microbubbles’
response to the acoustic field is stabilized, as the superheated liquid DDFP is, by
the albumin shell. Experiments proposed in Section 5.2.2 would contribute to the
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design of these droplets.
Some of the complications when droplets were combined with CA included the
need for PRF to be reduced in order for the supply of CA to be replenished as they
were destroyed in larger volumes than droplets were vaporized. If a microbubble
were attached to these droplets, then a vaporization event could occur with every
collapse of a microbubble. Seemingly, the effective zone for ADV would expand to
the effective zone for inertial collapse of CAs.
If successful ADV is attained with these coupled agents, a new and perhaps more
convenient method of ADV is available. Many US systems are currently equipped to
employ a technique to monitor local blood flow information by measuring real-time
refill curves [29]. In this technique, CAs flow through the vasculature and are allowed
to populate the volume of interest. Subsequently, a series of high mechanical index
(MI) pulses, employing the maximum acoustic power allowed by the diagnostic
machine, are fired transcutaneously and destroy all CAs in the imaging plane. The
refill of CA is then monitored. Because CA can be destroyed by an imager when
imaging an organ at depth, ADV could be also achieved with high MI pulses.
Exact alignment between therapy and imaging feedback, since they are the same
transducer, allows for simple targeting. The use of an imaging transducer can
additionally allow intercostal penetration to the kidney and electronic scanning for
complete occlusion of the target.
5.2.5 In vivo Demonstration
Thus far, in vivo demonstrations of ADV have been confined to a small animal
model without any acoustic attenuation from overlying tissue [4] . With the findings
from the in vitro work presented in this dissertation relating to attenuation effects
and strategies to reduce thresholds, current in vivo work applies these techniques to
a large animal model, where treatment is transcutaneous. CA are combined with
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droplets for injection, and PRF has been noted in vivo to have a deleterious effect if
it was too high. Like the previous study by Kripfgans et al. [4], droplet injections
are being performed intraarterially, but future work will transition to intravenous
injections, which will require much higher doses [2].
Phase Aberration Correction
Abdominal access for treatment of the kidney was considered here as the preferred
acoustic window. The abdominal wall was shown to cause appreciable attenuation,
but furthermore, appreciable aberration was also measured [7]. Microstructures
within the abdominal wall due to both muscle and fat tissue cause wavefront and
focus distortion. The ability to focus accurately will change from patient to patient
as both muscle and fat layers vary.
Thus, it will become important in transcutaneous treatment to be able to
refocus the beam for both accurate targeting and to achieve sufficient pressures.
Current research uses the bubbles created by ADV as point beacons to perform
time reversal [30] in order to penetrate through the skull and focus in the brain.
In time reversal, pulses are fired from individual elements on an US transducer.
As each wave propagates through a different path, it is aberrated and attenuated.
Consequently, the waves arrive asynchronously at the focus. Given a point beacon,
the asynchronous echoes can be recorded and time reversed. With the next pulse,
time delays are applied to each element such that the echo received last is transmitted
first, and the echo received first is transmitted last. Thus, temporal and spatial pulse
compression is achieved.
For ADV through the abdominal wall, echoes from the first bubbles created by
ADV could be time reversed and employed for subsequent insonation. For patients
with a highly aberrating abdominal wall, time reversal would significantly reduce
the amount of power output required by the system as well as provide a dependable
focal size and location. This consistency would increase repeatability and reliability
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of ADV treatments between patients, both of which are important for clinical
application.
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